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FOREWORD
This dissertation contains five chapters that broadly 
stated describe investigations of the structural and 
functional aspects of carbohydrates. Specifically, the 
study concentrates on the anion exchange protein 
popularly called band 3. The carbohydrate portion of 
band 3, called erythroglycan, has been the subject of 
much study. Two-thirds of the blood group determinants 
are estimated to reside in this portion of red blood 
cells and hence its importance cannot be overstated.
The first two chapters start with the functional 
aspects of erythroglycan. They deal with the suggested 
involvement of erythroglycan in the inhibition and 
possible binding of the human malaria parasite, 
Plasmodium falciparum. The first chapter details the 
inhibition studies of P. falciparum using various 
ligands. It also describes a binding experiment done 
with metabolically labe lied and solubilized parasites 
interacting with an affinity column activated with 
erythroglycan. It addresses most aspects of the problem 
of standardization by using four different strains of P. 
falciparum. Because the inhibition profile was nearly 
identical for all the strains with the ligands used, only 
one strain was finally chosen for subsequent studies.
The second chapter, "Decreased infectivity of 
Plasmodium falciparum malaria in HEMPAS red blood cells" 
will be submitted for publication to the Proceedings of 
the National Academy of Sciences (PNAS) of U. S. A* This 
observation also was presented at the 17^^ Annual Meeting 
of the Society for Complex Carbohydrates, at San Antonio, 
Texas, on November 3, 1988. HEMPAS is a type of human
red blood cell that bears a defective band 3 whose 
carbohydrate portion is truncated. A decreased P. 
falciparum infectivity was observed in these cells when 
compared with normal cells. A continuation of the first 
chapter, this chapter details the significance of the 
erythroglycan in P. falciparum invasion of red cells.
The third and fourth chapters are related to the 
structural aspects of the carbohydrates alluded to above. 
At the time of this writing, the third chapter is being 
readied for publication in the Journal of the American 
Chemical Society. In addition, most of the results 
mentioned in this chapter were presented at the 4 5 ^  
southwest regional American Chemical Society Meeting in 
Baton Rouge, Louisiana on December 6, 1989. This chapter 
involves the characterization of erythroglycan-related 
oligosaccharides. Three novel linkage isomeric
v
trisaccharides, containing residues found in 
erythroglycan, were characterized by high resolution NMR 
studies using one and two dimensional experiments. The 
structures were correlated to the molecular model of the 
compounds. Such small molecular weight organic compounds 
were amenable to characterization by these latest 
techniques and were used to determine the limits of 
resolution required to distinguish between closely 
related isomers. These were the first such studies of a 
family of linkage isomeric trisaccharides. Also, with 
these studies, the use of NMR was introduced into this 
laboratory, which is basically a carbohydrate laboratory, 
where traditionally the emphasis has been on the use of 
mass spectrometric methods for biomolecule characteriza­
tion. The fourth chapter is a continuation of the
third and contains detailed information vital to the 
experiments in the preceding chapter, but not included 
there because of journal space constraints. Some other 
experiments are described which are an addendum to the 
experiments in chapter three. Also, different novel di- 
and trisaccharides were characterized as described above. 
The NMR profile of some high molecular weight fractions 
of erythroglycan are also shown in this chapter and 
compared with results obtained with the synthetic 
oligosaccharides.
vi
Finally, model protein-1igand binding studies are 
detailed in chapter five. It would have been more 
appropriate to use a specific P. falciparum protein and 
study its binding characteristics vis a vis erythroglycan 
oligosaccharides. However, in the absence of any such 
clear-cut receptor, a model system was studied and is 
presented in this last chapter. Such model systems give 
accurate and simple means of extracting binding 
characteristics of ligand and possibly protein receptors. 
Thermodynamic parameters obtained from such studies 
preclude the need to synthesize large amounts of 
compounds for radiolabelling and inhibition assays, as is 
conventionally done. An extension of the application of 
these studies is discerning cell-biomolecule and cell­
cell communication, which is at the heart of solutions to 
most biochemical problems. The discussion of such 
systems completes the dissertation.
vi i
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ABSTRACT
Plasmodium falciparum is the parasite responsible for 
a major loss of human life due to malaria. The 
biochemistry of invasion of the parasite into human red 
cells is the subject of much study and controversy. The 
receptor mediated endocytosis of the parasite into the 
red cells is postulated to involve at least two major 
receptors on the cells.1 Earlier work focussed on 
glycophorin of red cells as a likely receptor. The 
present study focussed on the role of erythroglycan, the 
N-linked carbohydrate chain of band 3 of human red cells 
in the invasion process. Erythroglycan showed high 
levels of inhibition of malaria parasite invasion into 
human red blood cells. This implied its role as a 
receptor for invasion. These studies were corroborated 
by other studies such as affinity binding of parasite 
proteins. A 118 kDa protein is being reported for the 
first time as specific erythroglycan binding parasite 
protein. The involvement of erythroglycan in parasite 
recognition was also corroborated by studies with red 
cells defective in the carbohydrate portion of band 3 
from a HEMPAS patient. HEMPAS is characterized by a 
truncated erythroglycan. Parasite growth and invasion 
was decreased in HEMPAS cells compared with normal cells.
Structural studies of erythroglycan were carried out 
using smaller synthetic erythroglycan-like saccharides. 
High resolution NMR afforded information about anomeric 
configuration, epimer order, ring size and, most 
important, the linkage between saccharidic residues. 
Information obtained from such a study was used for the 
first time to discern the structure of intact, 
underivatized, high molecular weight (7 kDa) erythro­
glycan .
NMR titration studies were performed on Concanavalin 
A-methyl glucopyranoside. Analysis of thermodynamic 
parameters indicated unfavorable entropy but favorable 
enthalpy of binding. This indicates involvement of 
hydrogen bonds and van der Waal's forces. The model 
experiment can be applied to the study of larger 
biological systems.
xv ii
INTRODUCTION
The biochemistry of the invasion of malaria parasite, 
Plasmodium falciparum, is both complex and fraught with 
controversy. The parasite invades human red blood 
through a receptor-mediated endocytosis. Earlier, the 
search focussed on glycophorin of red cells as a likely 
receptor for invasion.1 The interaction is speculated to 
be due to positively charged proteins on the parasite and 
negatively charged sialic acids of glycophorin. 
Observation of normal invasion in certain red cells 
deficient in glycophorin prompted investigation into 
other receptors besides glycophorin. Primary among them 
is the carbohydrate portion of band 3, erythroglycan. 
Erythroglycan is a major topological determinant on human 
red cells. It would be logical to conclude that many, if 
not all, cell-cell interaction or cell-biomolecule 
interaction is mediated through such carbohydrate 
structures. Preliminary evidence implicating
erythroglycan in malaria parasite invasion proved 
promising1 and this aspect of the invasion process is 
reviewed in detail below. In light of these and other 
observations, structural and functional aspects of 
erthroglycan were undertaken and form the main substance 
of the research work detailed in this dissertation.
1
CHAPTER 1. P. FALCIP ARUM INVASION OF HUMAN RED CELLS: 
IN VITRO INVASION ASSAYS AND BINDING STUDIES.
2
3INTRODUCTION/LITERATURE REVIEW
Almost 2 billion people living within the tropical 
and subtropical regions of the world face a risk of 
malaria.2 Of these, about 200 to 300 millions suffer 
from the chi 11s, burning fever, headaches, nausea, and 
muscular pains of the disease. The most dreaded stage of 
the disease, called cerebral malaria, is fatal for most 
of about two million people each year. Apart from DDT 
(dichlorodiphenyltrichloroethane), chloroquine was one of 
the most successful drugs in recent years to be used 
against the disease. However, all advances made thus 
far against the disease were lost not only because of the 
ecological concerns regarding the use of DDT, but because 
mosquitos became resistant to DDT and the parasite 
responsible for the disease became resistant to 
chloroquine. Since such milestone discoveries, no 
further advancement has been made in the fight against 
the disease, despite the fact that the disease was 
described as far back as 5 B.C. by Hippocrates.4
Malaria is spread by the bite of the Anopheles 
mosquito.4 There are four species of a protozoan 
parasite responsible for the disease in humans, of which 
one of them, Plasmodium falciparum, is responsible for 
the greatest risk of complication and death. Of all the
4four species, only P. falciparum has become chloroquine 
resistant and is the subject of much study.
When a mosquito carrying the parasite bites a person, 
the Plamodium sporozoite enters the bloodstream, invades 
red blood cells and multiplies inside the cells until the 
cells burst.4 More parasites are released to continue 
the cycle of invasion. Inside red cells, the parasites 
progress through four stages of development. These 
are the ring, trophozoite, schizont and late schizont (or 
segmentor) stages. The late schizonts release merozoites 
into the blood stream and are ready for the next round of 
invasion unless taken up again by a mosquito bite, in
which case they can undergo different life cycles. The 
parasite cycles in patients are manifest by the onset of 
fever and subsequent remission and weakness felt by them, 
until the next cycle of reinvasion begins. In some
cases, the parasite may remain dormant for months or even
years before an attack may recur after periods of good
health. People living in regions where malaria is 
endemic are found to be more easily susceptible and 
affected by diseases which are treated easily elsewhere. 
This has caused some to believe that the malaria 
infection somehow suppresses the immune system of the 
victims, prompting some researchers to suggest the
5possibility that the immunosuppression may have made some 
people in central Africa susceptible to the AIDS virus.4
A multi-pronged attack is now being followed to stop 
the scourge of malaria. One strategy involves the use of 
new drugs that are effective against new strains. 
Chloroquine is most often administered in combination 
with one or more of several drugs that were recently 
designed, such as proguanil and pyrimethamine.3 The 
combined effect of the drugs probably overcome the 
chloroquine resistance in the resistant strains. On the 
biochemical side, vaccines are targeted against proteins 
that elicit a good antibody response and proteins that 
are postulated to be receptors of invasion. The latter 
study is part of an exciting subject of the biochemistry 
of the invasion mechanism. Many lines of evidence point 
to a multi-receptor mode of entry, and the object of 
the present study is to throw some light on this subject. 
Strong evidence is provided to implicate erythroglycan, 
the carbohydrate portion of band 3 on red cells as a 
1igand for at least two parasite proteins. In the light 
of its importance, structural studies of erythroglycan 
and erythroglycan-like ligands are presented.
6Biochemically, the disease of malaria provides an
interesting and stimulating area for research. It has
long been known that the parasite invasion of human red
blood cells is a process of receptor mediated 
1
endocytosis. This would most likely involve specific 
receptors on the parasite as well as human red cells. 
However, the studies done so far have only added to the 
complexity of understanding of the malaria receptor 
biochemistry. On the molecular level, the challenges 
have been in many arenas. Adding to these are 
complications of the recent cases of drug resistance in 
the evolving parasite, the mechanism of which has been 
described by Krogstad et al.5 Also, cases of survival of 
the parasites that evade destruction in the spleen by 
sequestration along the endothelium have been published 
recently.6
The sequence of events leading to the invasion by 
malaria parasites has been well documented in the case of 
P. knowlesi and erythrocytes from its natural host, the
, , *7 n
rhesus monkey, using interference and electron 
microscopy. The following steps are detailed in the 
invasion and can be safely assumed to be the same for 
parasites of other species or strains: (i) initial
7attachment of the merozoite by accidental contact with 
erythrocyte membrane; (ii) junction formation between the 
apical end of the merozoite and the erythrocyte; (iii) 
creation of a vacuole membrane continuous with the 
erythrocyte membrane; (iv) invagination of the merozoite 
into the vacuole by a moving junction around the 
merozoite; and (v) sealing of the vacuole membrane after 
completion of invasion. The cytoskeleton of the 
erythrocyte first resists the interaction but then allows 
the invasion to proceed. Electro-optical studies of P. 
falciparum invasion show a similar behaviour of 
invasion, with some minor differences.9 A defect 
manifested in any one of these steps would block invasion 
of the erythrocytes by the parasite. It had been 
suggested as far back as 1973 that the initial attachment 
or subsequent movement of the parasite could involve 
specific receptors on both the merozoite and 
erythrocyte.10
In the present study, the focus is on the 
details of mechanism of invasion, with special emphasis 
on receptors of the human red blood cells. Most 
biological and patho-physiological processes are the 
result of cell-cell and cell-molecule recognition. 
Membrane glycoproteins constitute the furthest 
extremities of cells. It would be quite rational to
8assume that they are predominantly involved in such 
recognition processes. In the early seventies, many
researchers reported the presence of glycosylation of 
membrane proteins on the external surfaces of
1 1 — 1 Tcells. The cell recognition system would most
likely involve carbohydrate structures for specific
interactions. Since the variety of carbohydrate
structures possible for a given sequence of
monosaccharides is much larger than a similarly sized 
protein or nucleic acid molecule, the immense
possibilities, variations and immunomodulation afforded 
by such structures could allow for a greater amount of 
manipulation of interactions.
Many possible recognition sites for the parasite 
attachment prior to invasion of the red cells have been
proposed. The red cell receptor of malaria has been
defined in some detail in only three of the species of 
Plasmodium: P. falciparum, P. vivax and P. knowlesi. A
brief account of these will be given here, along with a 
critical appraisal of each.
For P. vivax and P. knowlesi, the major receptor is 
the Duffy glycoprotein. The natural host of the former 
parasite is human, whereas for the latter it is the 
rhesus monkey. There is limited data on the biochemical
9nature of the Duffy glycoproteins. Preliminary evidence 
indicates that the glycoproteins are multimeric subunits, 
with a soluble extract of 35-88 kDa.14“17 The
Duffy blood group system is defined by antisera anti-Fya 
and anti-Fyk. out of the four phenotypes, Fy(a+b-), 
Fy(a-b+), Fy(a+b+), and Fy(a-b-), the Fy(a-b-) cannot be 
infected by human malaria parasite P. vivax.18 This 
observation implicates the Duffy antigen in the malarial 
invasion by P. vivax. Similar results are obtained using 
P. knowlesi.19, 20 P. berghei, P. yoelli and p.
chaJbaudii are specific malarial parasites of rodent 
systems. However, the receptors in this area remain 
largely unexplored.
Glycophorin as the first site of recognition:
The P. .falciparum species seems to use an entirely 
different receptor for invasion. These differences are 
postulated to be due to evolutionary pressures.2 "^-24 
Initially, in the early 1980s the search for a receptor 
was largely focussed on glycophorins A, B and C. Prior to 
speculating about the possible role of glycophorins in 
malaria invasion some background information about their 
function and structure with relationship to malaria 
receptors will be provided.
Glycophorin A consists of 131 amino acids the 
sequence of which was reported in 1978. The blood
10
group epitope MN resides on glycophorin A. Glycophorin A 
has a molecular mass of about 31 kDa, 60 % of which is 
carbohydrates.There are fifteen O-linked and only one 
N-linked sugar chains on glycophorin A. The O-linked 
structure on serine or threonine is alkali labile and is
a tetrasaccharide as reported in 1969 by Thomas and
* on *Winzler^ (figure la). The structure of the N-linked 
sugar chain on asparagine-2 628 is a complex type sugar, 
with a bisecting N-acetylglucosamine (GlcNAc)28' 30 
(figure lb). The nature of the amino acids at the N 
terminal portion of glycophorin A determines the M or N 
blood group specificity. Glycophorin A has serine and 
glycine in the M antigen activity whereas it has leucine
0 fiand glutamic acid in the N antigen activity. ° However, 
no differences in behaviour were obtained with invasion 
studies dqne with P. falciparum using glycophorin A with 
MN, MM or NN activity.22 Hence, glycophorin A will be 
treated as such without further specifying the antigen 
type.
The blood group Ss resides on glycophorin B,
which is identical to the N-specific glycophorin A
through residue 26. Between amino acids 26 and 35,
the residues differ and this is the region that carries
3 1the Ss antigen specificity in glycophorin B. A Also, the
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asparagine, Asn-26, on glycophorin B is not glycosylated 
as in glycophorin A.
Glycophorin C has an average of twelve O-linked and 
one N-linked sugar chains. The N-terminal sequence of 
glycophorin C was recently reported.32 Residues 25-28 
and 29-33 of glycophorin C are similar to residues 1-4 
and 8-12 of glycophorin A and B. In addition, the 
sequence Ala-Gly-Val-Ile occurs within the intra- 
membraneous domains of both glycophorin A and C.
All the glycophorins are rich in sialic acid residues 
which sets them apart from other glycoproteins such as 
the N-linked sugar chains of erythroglycan. These sialic 
acids, as will be discussed below, are thought to be 
crucial for the initial attachment of the P. falciparum 
parasite. ,
The possible involvement of glycophorin A as the 
malaria receptor was reported simultaneously by Perkins23 
and Deas and Lee,33 using glycophorin A or a mixture of 
sialoglycoproteins as inhibitors of invasion. This work 
has since been duplicated by Hermentin and Enders34 and 
o t h e r s . J Indirect observation of the involvement of 
glycophorin A was obtained by in vitro testing of red 
cells that were deficient in glycophorin A, called En(a-) 
cells. Miller et al.38 in 1977 reported finding
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reduced susceptiblity of such cells to invasion 
compared with invasion in normal cells. This work was 
later confirmed by Pasvol et al.22 in 1982 and Facer39 in 
1983 .
The involvement of glycophorin B in P. falciparum 
invasion was reported simultaneously by two laboratories 
in 1982. Pasvol et al.40 and Howard et al.41 reported 
the decreased susceptibility of glycophorin deficient 
cells, or S-s-U-cells to invasion compared with normal 
cells. This study was confirmed by Facer.39 Glycophorin 
A and C from these cells were subjected to trypsin 
treatment, which reportedly cleaves glycophorin A and 
leaves glycophorin B intact.26 Perkins42 also 
reported the inhibition of P. falciparum invasion by 
purified glycophorin B, a study confirmed by Hermentin 
and Enders.34 However, glycophorin B was less inhibitory 
than glycophorin A. Red cells possess four times more 
glycophorin A than B, thus further increasing the 
probability of invasion through glycophorin A.43
Among other results obtained implicating glycophorin 
A as a receptor was the reported observation of 
refractoriness in Wr*3 antigen. 9, 40, 44 This antigen is
present on the internal domains and outer portion of 
glycophorin A. When antibodies directed against
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this domain in cells from normal individuals were used, 
the invasion was reduced.40 Reduced invasion of human 
red cells carrying rare blood group antigens, such as 
Tn40, 45 or Cad45 furthered the possibility of
glycophorin as a possible receptor. Both Tn and Cad
cells express distorted O-linked tetrasaccharides of 
glycophorin. In yet another vindicating study, 
glycophorin-coupled CNBr-Sepharose was found to bind two 
radiolabelled schizont proteins (140 kDa and 35 kDa) of a 
P. falciparum isolate.46 These were eluted with GlcNAc, 
suggesting a role for the sugar portion of glycophorin in 
receptor recognition. By contrast, glycophorin-coupled 
aminoethy1-BioGel bound 130 kDa and 155 kDa proteins of a 
different isolate, FCR 3 of P. falciparum.47
Studies with rare blood groups also helped define the 
regions within glycophorin which could be involved in
parasite recognition. Normal invasion was observed in
homozygous MgMg red cells which carry defective
sialotetrasaccharides on the outer positions (amino
acids 2, 3 and 4) of glycophorin.45 Thus, it is likely
that this region of glycophorin is not involved in
parasite interaction. Otherwise, there is strong 
evidence to implicate a role for sialic acids on
glycophorins in the invasion process. Sialidase and 
trypsin treatment of cells reduced parasite
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invasion. 23 ' 37 There are about 1 X 106 molecules of
glycophorin A34 on each red blood cell, a fourth 
that number of glycophorin B26' 43 and a tenth of 
glycophorin C34. Glycophorins A, B, and C account for 
60, 15 and 5 percent of sialic acids on red cells, 
implying a high probability for the involvement of 
glycophorins.
Among the many criticisms mounted against malaria 
inhibition studies in general and glycophorin as a 
receptor in particular, the most serious were those that 
claimed some amount of toxicity in glycophorin 
preparations. Hermentin et al.48 described the effects 
of incubation of various glycophorins, desialylated 
glycophorins, sodium borohydride treated glycophorins and 
the O-linked tetrasaccharide isolated from glycophorin A 
on the invasion of human red blood cells by P. 
falciparum. Using both radiolabel incorporation studies 
and toxicity tests they were able to pinpoint portions of 
glycophorins which could possibly cause the toxic effect. 
Their toxicity tests involved the observation of parasite 
growth on Giemsa-stained thin smears. Observation of 
parasites degenerating to a late ring stage, while 
control cultures developed to an early schizont stage, 
were certain signs of toxicity. Intact glycophorins 
exhibited partial toxicity at 20 uM concentrations while
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chymotryptic fragments did not. The chymotryptic 
fragments are devoid of the hydrophobic regions and hence 
the toxicity was attributed to this portion of
glycophorin. Surprisingly, the O-linked tetra-
saccharide exhibited toxicity at 500 uH, but as part of 
the chymotryptic fragment, it did not.
The same mechanism is believed to work in the case of
, A Q ,
inhibition by the ganglioside Gmla. According to the
authors, this inhibitor could be inserting into the
membranes of either or both the red cell and the
parasite, causing apparent inhibition. In fact, the only 
reason the ganglioside could be acting as an inhibitor
could be because of its effects on one of the steps 
involved in the parasite invasion outlined above without 
having to act as a receptor.
Other problems encountered were the irreproducibility 
of results. Contradictory results were reported in 
susceptibility tests with the Wright blood group antigen. 
Subsequent exhaustive studies in several laboratories, 
including Hermentin's, showed that the cells were fully 
susceptible to invasion.^0”54
In the study involving the glycophorin-activated AE- 
BioGel columns mentioned above,47 erroneous results were 
most likely obtained because of the absence of an
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appropriate control. Schravendijk et al.55 reported that 
AE-BioGel itself, even in the unactivated form, bound to 
FOR 3 strain proteins in large numbers, and was highly 
selective for the two proteins mentioned above (130 kDa 
and 155 kDa). The binding was probably due to the highly 
positively charged nature of AE-BioGel. Though this 
observation does not necessarily exclude the possibility 
that some of the parasite proteins did interact with 
glycophorin, the results obtained using glycophorin­
coupled Bio-Gel must be interpreted with caution.
The search for an additional, if not alternative, 
receptor was speeded by the discovery that falciparum 
malaria parasites invaded MkMk erythrocytes normally. 
MkMk erythrocytes lack glycophorins A and B. The low 
level of glycophorin C present on cells cannot explain 
the normal invasion in such systems.56
The contradictory results and evidences obtained 
using glycophorin do not eliminate it as a possible 
receptor. The differences in behaviour between strains 
and their effect on natural host or unnatural 
erythrocytes was explained by Perkins21 as resulting 
from variants of the antigenic proteins that are involved 
in invasion and were selected in response to immune 
pressure. Thus, the new or modified protein was able to
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interact with erythrocyte membrane components in some 
cases and was unable to do so in others. Alternatively, 
evolutionary lineages of P. falciparum species evolved at 
different rates and some lost their ability to invade 
their original natural host. P. falciparum is closely 
related to the rodent malaria species. It is likely that 
some strains that diverged from the rodent strains lost 
their ability to interact with mouse erythrocytes, which 
have differences in most of their sialic acids, and are 
9-0-acetylated. Other strains that still invade mouse 
erythrocytes57 or sialic acid deficient human red cells 
may have diverged less. Though these explanations are 
speculative at this stage, the supporting observations 
lend credence to the outlined theories.
A "two distinct receptor site" theory also has been 
proposed to explain most of the observations involving 
glycophorins.37' 40' 42' 58-62 According to this theory,
P. falciparum utilizes two receptors for invasion: Pf200 
(or gpl95) and a 175 kDa protein. Glycophorin is also 
postulated to have two sites of interaction with the 
parasite. Most invasions occur through interactions of 
Pf200 with sialic acids. Unusual observations are 
explained as being caused through Pf200 independent 
mechanisms. This theory, however, was discounted by 
Hermentin et. al48 in light of the observation of the
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partial toxic effect of inner portions of glycophorin and 
the refractoriness of Wright*3 antigenic erythrocytes to 
invasion.
The contradictory observations and toxicity observed 
in studies involving glycophorins do not completely 
exclude glycophorin as a receptor for P. falciparum 
invasion of human red cells. They may play a role in the 
initial attachment of merozoites as originally proposed 
by Friedman et al.63 This attachment could include an 
ionic interaction between the sialic acids of glycophorin 
and positively charged proteins on the surface of the 
parasite. Glycophorins, being transmembrane proteins, 
could then play a role in information transfer to band 
4.1 and thence to spectrin. Alternatively, due to their 
close proximity to band 3, they could interact with 
spectrin via ankyrin. Red cells lacking glycophorin- 
band 4.1 interaction, resist P. falciparum and P. 
knowlesi invasion.64 This interaction is assumed to be 
crucial for cell shape maintainance.65 The initial stages 
of invasion destroy this interaction and along with it, 
cell shape. This may be necessary for the reorientation 
and apical attachment of the merozoite on the red cell 
surface. The following zipper-like interaction would 
precede the breakdown of the cytoskeletal network, 
especially at the site of attachment, suggesting the
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involvement of more than one receptor. Junction 
formation during the sequence of events preceding 
invasion requires a stronger, possibly lectin-like, 
interaction between parasite proteins and erythrocyte 
ligands. The subsequent enhancement of fluidity, a
prerequisite for the invagination prior to complete 
invasion, completes the entry of the parasite into the 
host cell.
Band 3 as a possible candidate receptor:
The structural details of band 3 and its 
carbohydrates are discussed in chapter 4, which forms a 
major portion of the structural elucidation of
erythroglycan, the carbohydrates on band 3.
Before the start of this project, initial evidence
involving a likely role for band 3 in the human malarial 
parasite invasion was reported by two groups, including 
this laboratory.66' 67 The group of Okoye and Bennett66 
reported inhibition of P. falciparum at nanomolar levels 
of human band 3 incorporated into liposomes. This
inhibition was six times more effective than glycophorin 
liposomes. Liposomes alone did not inhibit the parasite. 
Friedman et al. reported higher molecular weight 
erythroglycan glycopeptides as the most potent 
inhibitors of invasion. This, they suggested, implied
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band 3 may be involved in some stage of erythrocyte 
invasion by P. falciparum parasites.
Initial evidence from invasion studies with 
ovalocytic red cells bearing defective band 3 was
misleading. Nonhemolytic ovalocytosis in Malayan 
aborigines is known to be the cause of a dominantly 
inherited resistance to malaria.68 In vitro assays 
showed P. falciparum resistance to invasion in such
6  Qcells. J However, it was later reported that these 
cells have decreased membrane deformability.70 This is 
likely only if the defect in band 3 is on the cytoplasmic 
side, where it interacts with the cytoskeleton. Indeed, 
the defect in band 3 was shown very recently to be in the 
amino or cytoplasmic terminus.71
The studies with red cells defective in band 3 are 
just beginning. Because evaluation of band 3 as a 
receptor for malaria had a late start, it is likely that 
details have yet to unfold to give a clear picture. A 
beginning was made in this laboratory with the
observation that a reduced infectivity profile was 
obtained with HEMPAS cells in comparison to normal
cells (Dhume et al., manuscript in preparation. Also, 
see chapter 2). HEMPAS is hereditary erythroblastic 
multinuclearity with positive acidified serum test and is
a condition of hemolytic anemia. The only biochemical 
difference between such cells and normal cells is the 
presence of a truncated erythroglycan on band 3. Since 
the defect in band 3 is at the outer portion of the 
cell, reduced invasion assays in such cells would, 
without doubt, implicate band 3 and especially erythro­
glycan, in the Plasmodium invasion. Invasion and growth 
was reduced in such cells in comparison with normal red 
celIs.
Indirect evidence implicating band 3 in parasite 
invasion came with studies involving anti-band 3
7 2
antibodies. A monoclonal antibody directed against the 
rhesus erythrocyte band 3 inhibited invasion by P. 
knowlesi merozoites. Though a different system, the 
study assumes importance in the context of the present 
work, because of two reasons: first, P. knowlesi, a 
monkey malaria has been reported to invade human erythro­
cytes;73, 74 and secondly, the study stated that there 
was no blocking of parasite binding by the antibody. 
This suggests that the band 3 was involved in a step in 
invasion after initial attachment, a suggestion that 
vindicates the postulate made above, regarding the late 
stage of band 3 involvement.
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A recent report on naturally occurring anti-band 3 
autoantibodies present in normal human serum may hold 
important clues that directly implicate band 3 as a 
receptor recognized by P. falciparum.75 Erythrocytes 
infected with the knobby variant of P. falciparum 
expressed significant amounts of an antigen that reacted 
with an anti-band 3 autoantibody-activated thiol- 
Sepharose column. It was not known however if the band 3 
antigen expressed after invasion was modified due to the 
parasite interaction during invasion, or whether it 
senesced due to secondary factors associated with the 
invasion. In the absence of further investigation, the 
observation remains an interesting piece of information 
that may be used in the future to corroborate malaria 
receptor theories.
Lastly, two observations need to be mentioned here 
since they have clear implications for the involvement of 
band 3 in P, falciparum invasion. The lack of inhibitory 
effect of alpha-l-acid glycoprotein (orosomucoid) was 
declared to be the reason band 3 could not be the 
receptor. 76 The sugar component on orosomucoid was said 
to be similar to the one on band 3. This is far from the 
truth. Though they may contain the same residues, 
millions of structures can be formed from such 
components. In nature, many structures have been found
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and are being reported. A slight variation in structure 
can cause a large difference in saccharidic structure due 
to large conformational differences in small changes. 
Human orosomucoid was recently reported to contain two
* 7 7types of chains: mono- and bi-antennary. A large
amount of fucose is linked to N-acetylglucosamine 
residues. Large amounts of sialic acids are also 
reportedly present. Erythroglycan is a bisected 
biantennary structure with a high level of branching, the 
structure of which is discussed in detail in chapter 4 
below. What was surprising was the lack of inhibition 
despite the presence of negatively charged sialic acids. 
This observation cannot be ignored. Inhibition in 
unexpected cases can be explained on the basis of 
possible toxicity or other problems, but the lack of such 
inhibition cannot. It is likely that other parts of the 
ligand in the orosomucoid preparation shielded the sialic 
acids or parts of the extracted protein neutralized its 
effect and interacted favorably with the parasites and 
allowed invasion. Further speculation has to await 
detailed orosomucoid structure or a repeat of the 
invasion assay.
Observation of inhibition by human plasma fibronectin 
vindicates the involvement of band 3 carbohydrates.78 
These two glycoproteins have similar carbohydrate
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7 Qstructures. According to Nichols et al. each protein 
has two glucosamine based and one galactosamine based
sugars. In fibronectin, these are predominantly
biantennary, with the following sialosyl type 2 chain, 
lacking fucoses: NeuAc2-3/6ftGall-4BGlcNAcl-3/6BGal.
This is identical to the polylactosaminyl structures
found on erythroglycan, which however, lacks the presence 
of large amounts of sialic acids. Thus, fibronectin
could function both as glycophorin, in possessing the 
requisite negative charge, and as erythroglycan-like
saccharides for subsequent lectin type binding of 
parasites.
Before the start of the experimental section, the 
possible pitfalls in the invasion assays and binding
studies are mentioned and the ways to circumvent them 
addressed. Some of the problems that were mentioned 
above were unique to the case of glycophorin, such as the 
toxicity of some portions of the protein. However, other 
problems affect most malaria studies, and these need to 
be resolved. Problems involving standardizations, such 
as differences in strains, age and handling of human red 
cells, different experimental designs and culture 
techniques are very difficult to eliminate because of the 
the number of researchers involved who work with 
various strains and techniques. However, lack of
25
synchrony of cultures, lack of viability of parasites, 
impurity of ligands used, and most important of all, the 
question of toxicity of inhibitors are easily addressed. 
The question of toxicity deserves special mention. The 
latter is most often confused with inhibition. Also, it 
appears in cases where it is least expected. To give an 
example, several ligands were tested by Hermentin et
o n ,
al. , u to arrive at a general conclusion regarding 
toxicity of different chemical groupings. They found 
that hydrophobic or aromatic moieties in ligands were 
toxic to parasites, causing erroneous claims of 
inhibition in many cases. Such structures are 
extensively used in the synthesis of neoglycoproteins as 
spacers between sugars and the protein. Since most 
inhibition work described below used neoglycoproteins, 
this study assumed considerable importance. Conventional 
spacers were avoided and an alternate method was devised 
that used the sugar itself as a spacer. The procedure is 
detailed in the experimental section below. Cultures 
were synchronized using established methods and verified 
by microscopic examination before use in invasion assays.
Four different strains of P. falciparum were used in 
the first experiment of inhibition with erythroglycan. 
Though by no means an exhaustive study of different 
strains, it was nevertheless an attempt to observe a
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general trend of differences, if any, in the behaviour of 
strains. In the event of such differences, all 
subsequent experiments would have to be repeated or at 
least carried out using all the different strains. 
Otherwise, no general conclusions could be possibly drawn 
for the species. Fortunately, with the observation 
that the strains behaved identically with respect to the 
ligands, only one strain (SLD6) was finally chosen 
for subsequent studies.
The question of ligand purity also was addressed. 
Established procedures were followed to make such ligands 
and subsequent instrumental analysis was done to check 
for purity. As detailed below in the experimental 
section, ligands were used after confirmation of the gel 
filtration or gas chromatographic profile of the samples. 
In most cases, normal eluants were replaced with 
distilled water to be run in the cold and samples frozen 
or lyophilized immediately after detection.
In all experiments dealing with malaria, these 
concerns were addressed as much as possible. 
Experimental and culture techniques from reputed 
laboratories were followed with consistency. Recent 
modifications, if any, were incorporated. Consistently 
good results were obtained with the methods outlined
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above. The involvement of erythroglycan in P. falciparum 
invasion was shown in three independent experiments 
detailed below. This study was supported by the 
observation of high affinity binding of falciparum 
polypeptides to human band 3.81 The latter study used 
parasite polypeptides interacting with human red cells 
for binding studies. Hence, the polypeptides cannot be 
contaminated with cytosolic or other non-specific binding 
parasite proteins, the usual problem with such studies.
Three experiments are described in this chapter, the 
first dealing with erythroglycan inhibition of four 
different strains of P. falciparum, and attempts to 
address the problems with strain differences. The second 
experiment concerns the comparison of inhibition of P. 
falciparum using different neoglycoproteins and their 
free sugars and the third involves binding studies of P. 
falciparum proteins to erythroglycan affinity columns.
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MATERIALS AMD METHODS
EXPERIMENT ONE
Preparation of erythroglycan:
Three bags of expired packed human red cells 
with about 2 50 ml blood in each were obtained from the 
local community blood center. Ghosts were obtained from 
the cells using the method of Dodge et al.82 Briefly, 
erythrocytes isolated by centrifugation, were washed 
three times with isotonic PBS (phosphate buffered 
saline), pH 7.4. The cells were then hemolyzed in 30 
volumes of hypotonic phosphate buffer, pH 7.4. The 
membranes were concentrated in a 20 u membrane concentra­
tion system (Millipore corporation) and washed to remove 
most of the hemoglobin.
Small glycolipids and gangliosides were removed as 
reported by Krusius et al.83 Briefly, the packed 
erythrocyte membranes were homogenized in 6.66 volumes of 
methanol and 13.33 volumes of chloroform, and filtered or 
centrifuged. The membranes were rehomogenized in five 
volumes of chloroform-methanol (1:3 v/v), centrifuged, 
and lyophilized. The water-butanol extraction of 
poly(glycosy1)ceramides was omitted, because these can be
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removed from the erythroglycan fractions in subsequent 
steps.
Glycopeptides were then prepared by pronase 
(protease, type VI, Sigma Chemical Company) digestion
D A
according to Jarnefelt et al. The glycopeptides
obtained were dried by rotary evaporation.
The dried sample obtained above was then 
chromatographed on a Bio-Gel P-2 column, and fractions 
were tested for carbohydrate by the phenol, H2S04 test.85 
Positive fractions were pooled and dried to obtain about 
80 mg of solid to give a yield of about 90 percent of 
crude erythroglycan. The solid was dissolved in 
distilled water and applied to a Bio-Gel P-10 column (bed 
volume 125 ml, 1.7 X 55 cm) and fractions eluted with 
distilled water in a cold room at 4 °C. The change in
the eluting solvent from the one reported (100 mM
pyridine-acetic acid buffer, pH 5) 84 was made to 
facilitate the malaria parasite inhibition studies using 
erythroglycan, without the interference of even trace 
amounts of the buffer. About 2 ml fractions were 
collected and 100 ul of each was assayed for 
carbohydrates. The profile obtained is shown in figure 
2. Fractions with a molecular mass greater than the 3
KDa were pooled and dried by rotary evaporation for
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inhibition studies. Erythroglycan fractions less than 3 
kDa were contaminated by high molecular weight fractions 
of polyglycosyl ceramides. A flow chart for the 
preparation of erythroglycan is shown in figure 3.
Inhibition assays using metabolically labelled parasites:
Four strains of P. falciparum were obtained from Dr. 
Phuc Nguyen Dinh of the Center for Disease Control, 
Atlanta, Georgia. These are the FCRK+, FCRK-, PAP 
(Honduras) and SLD6 (Sierra Leone) strains. Each strain 
was maintained in continuous in vitro conditions of
Trager and Jensen.8® Before the inhibition experiments, 
the parasites were enriched in the ring stage by isotonic 
mannitol treatment.87 This involved isolating the 
culture by low speed centrifugation followed by 
incubation in 20 volumes of 300 mM mannitol in 5 mM Tris- 
HC1 for 20 minutes at room temparature. Cultures were
then centrifuged at 200 X g for 10 minutes to obtain the
synchronized parasitized red cells.
Trypsin treatment of the cells was then done 
using the method of Schrevel et al.88 Briefly, 
parasitized cells were trypsinized (Trypsin type XIII, 
Sigma Chemical Company) at 37 °C for 1 hour. The cells 
were then washed in 50 volumes of growth medium (RPMI- 
1640, 25 mM HEPES, 32 mM sodium bicarbonate, all from
Sigma) containing 10 % human serum, then incubated in 
culture conditions. Before the next cycle of invasion, 
50 ul of the synchronized, parasitized culture was placed 
in 96 well microtiter plates and incubated overnight in 
the presence or absence of different concentrations of 
the ligand, ranging from 0 to 10 mg/ml. Triplicate 
readings were taken for each concentration of ligand. A 
positive control of heparin was also used for comparison. 
A control for toxicity consisted of monitoring the 
incorporation of ^H-hypoxanthine in independent wells 
corresponding to the above concentrations, the only 
difference being that the incorporation was measured 
during the second life cycle of the parasite. Prior to 
that time, media was carefully removed at 24 hour 
intervals and replenished with fresh amounts of the same. 
3H-hypoxanthine incorporation was measured after cell 
harvestation using the Titertek cell harvestor 530/550 of 
Flow laboratories, Ayrshire, Scotland, followed by 
addition of 1 ml of Liquiscint (National Diagnostics, 
Somerville, NJ) and counting on a Beckman LS 250 
scintillation counting instrument. Since the cell 
harvestor works by harvesting cell membranes onto glass 
fiber filter paper, radiolabel associated with the red 
cell, if any, would also be included in the final 
reading. Therefore, another control was run by
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incubating equal amount of red cells in independent 
microplate wells, in the presence of 3H-hypoxanthine for 
the duration of the experiment. These cells were then 
washed three times in isotonic PBS (see above), and the 
associated counts were measured as above. The results 
are shown in table 1 and figure 7.
EXPERIMENT TWO 
Preparation of free sugar ligands for inhibition 
experiments: 
Maltooligosaccharides as the free sugars (M):
Glucose, ma1totetraose and maltoheptaose were obtained 
from Sigma Chemical Company, St. Louis, MO.
Preparation of chitooligomers as the free sugars (C):
Chitooligomers of various sizes were obtained from 
crab shell chitin (Sigma Chemical Company), by chitinase 
(Sigma Chemical Company) digestion using a modification 
of the method of Fuchs et al.89 Briefly, 500 mg of 
chitin was suspended in a 0,1 M buffer, pH 6.0 at 50 
°C for 2 hours and the chitinase precipitated by 
trichloroacetic acid (TCA). The reaction mixture was 
centrifuged on an IEC bench top centrifuge at high speed 
for 15 minutes. The resulting supernatent was 
lyophilized for several hours till dry and then dissolved
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in 1.5 ml of 10 % ethanol and applied to a Bio-Gel P-2 
column (bed volume 90 ml, 1.7 X 40 cm), for a one-step 
separation of the buffer, and salts, and for a suitable 
fractionation of the oligomers. The sample was eluted 
with distilled water as the eluent, and 1.2 ml fractions 
were collected and tested for a general profile of sugars 
by TLC (Silica Gel G of Analtech, Newark, DE) using 
CH-jCN:H20 = 4:1 as eluant. Sugars were visualized with 
with 50 % H 2 (figure 4a) . Amino sugars were
quantitated at 585 nm according to Reissig et. al.90
Briefly, the sample was incubated with potassium 
tetraborate at 100 °C and pH 9.1 for 3 minutes, cooled 
in tap water, added to 600 ul of 1:10 dimethy1-amino- 
benzene in glacial acetic acid and the pink color read 
spectrophotometrically at 585 nm. The readings were 
compared with standard N-acety1-glucosamine to determine 
the amount of sugar as moles of monosaccharide. This is 
a standard method for the determination of amino sugars 
but suffers from one disadvantage. Due to incomplete 
hydrolysis of the chitooligomers, the method 
underestimates the amount of higher molecular weight 
amino sugars. However, for a general idea of the profile 
and the detection of amino sugars, this method is very 
useful. An estimate of the molecular weight of the 
sugars was made from the standardized P-2 column,
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and the test for amino sugars was used for an estimate 
of the amounts which was later quantitated by gas 
chromatographic (GC) analysis (f igure 5a) . The 
positive fractions were collected into 5 pools to 
corresponding to the molecular weight distribution of 
chitooligomers obtained with HCl treatment as described 
below. They were lyophilyzed overnight until dry and 
frozen before their use in invasion assays.
Preparation of erythroglycan as free sugars (EG):
EG for this part of the experiment was prepared 
exactly as described above, except that it was 
chromatographed on a Sephadex G-50 (Pharmacia,
Piscataway, NJ) column with a bed volume of 125 ml (1.7 
X 55 cm) at 4 °C. 1.5 ml fractions were collected
using distilled water as eluent and monitored using a 
densitometric assay. One ul of each sample was 
spotted on TLC plates, sugars visualized by spraying with 
orcinol+H2S04 as described above, and spots 
densitometrically compared with standard glucose 
concentrations. Results are shown in figure 6a. Three
pools were chosen as shown: pool 1 was 10 kDa and above,
pool 2: 3 to 10 kDa and pool 3: less than 3 kDa. The
pools were dried by lyophilization. Half of each pool
was reserved for synthesizing neoglycoproteins, the
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other half was used as free sugars for inhibition 
studies.
Preparation of sugar components for Neoglycoproteins:
Neoglycoproteins of Erythroglycan, galactose, 
maltotetraose, maltoheptaose and chitooligomers were 
made. Bovine serum albumin (BSA) was used as the protein 
portion of the neoglycoprotein. Lysyl amino groups on 
BSA react with aldehydic groups on the reducing sugar to 
form a Schiff base which is irreversibly reduced with 
sodium cyanoborohydride to give the neoglycoproteins. 
Each of the sugars to be used was obtained using a method 
different from the one used above. The chitooligomers 
were obtained by hydrolysis using HC1 rather than by 
chitinase digestion. A higher yield was obtained using 
the former method, and it was easier to separate the 
neoglycoprotein from the rest of the reaction products, 
obviating the need to separate the enzyme. The procedure 
was much different with the erythroglycan (EG) 
preparation. EG was obtained with a combination of 
conventional and a new enzymatic method, involving N- 
glycanase treatment. The use of glycanase exposed the 
reducing sugars from erythroglycan which were then used 
for the coupling reaction. The enzyme cleaves between 
the two N-acetylglucosamine residues closest to the 
peptidy1 asparagine, leaving one residue of sugar in
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reducing form and free for the coupling reaction with 
BSA, as shown in figure 7.
Preparation of chitooligomers free sugars for 
neoglycoproteins:
Chitooligomers were prepared and extracted according to
q  i , q  o *
Rupley3_L and Nishimura.  ^ Briefly, 10 g of crab shell 
chitin (Sigma Chemical Company) was digested with 100 ml 
of conc. HCl at 37 °C for 15 hours, added to 1.2 1 of
distilled water, and filtered using a glass fiber filter 
paper (Gelman Instrument Company). The filtrate was 
stirred 1 hour with 15 g charcoal and filtered again. 
Chitooligomers were extracted from the charcoal with 1 1 
of a 10 % and then 10-60 % cut of ethanol. Each extract 
was concentrated on a rotary evaporator to about one ml, 
added to l gm of cation exchange resin, 200-400 mesh 
(Bio-Rad AG-50W—X4), stirred for 2 hours and filtered. 
The filtrate was dried on a rotary evaporator, dissolving 
most of it in distilled water and discarding the 
insoluble portion. One ul of sample was subjected to TLC 
(Silica Gel G of Analtech), with 1:4 CH3CN:H20, and 
sugars detected by 50 % H2S04. The results are shown in 
figure 4b. The 10 % cut yielded primarily the monomer, 
whereas the 10-60 % cut yielded the mono to higher
oligomer in the extract. The 10-60 % cut was then
chromatographed on a Bio-Gel P-2 column (90 ml bed
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volume, 1.7 X 40 cm) in the cold and eluted with
distilled water. Fractions were analyzed as described 
above in the preparation of oligomers by chitinase 
digestion, pooled appropriately (to correspond to pools 
of chitooligomers obtained by the enzyme digestion), 
dried by lyophilization, and frozen for future use. The 
profile results are shown in figure 5b.
Preparation of erythroglycan free sugars for 
neoglycoproteins:
Erythroglycan was isolated as a glycopeptide 
according to the procedure described above. Then, endo- 
fl-N-acetylglucosaminidase F (N-glycanase) was used to 
hydrolyze the sugar-peptide bond.93 Though N-glycanase 
should hydrolyze most N-linked sugar-protein bonds, the 
enzyme would not cleave sugars from intact band 3 in 
delipidated membranes. This was probably due to 
insolubility of the substrate.
N-glycanase from a culture of Flavobacterium 
meningosepticum was kindly donated by Dr. John H. Elder 
of the Scripps Clinic and Research Foundation, La Jolla, 
California. N-glycanase was isolated from the bacteria 
according to Tarentino et al.93 Briefly, an overnight 
culture of F. m&ningosepticum was centrifuged at 8000 X g 
for 30 minutes, the supernatent stirred with 10 mM EDTA
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in the cold for 10 minutes, the protein salted out using 
70 % (NH4 )2S04, dialyzed overnight against DEAE buffer 
0.01 M buffer, pH 7.2, 2 mM NaN3, and 10 mM EDTA) ,
loaded onto a DEAE-Biogel A column in the cold and 3.5 ml
fractions collected using the DEAE buffer as eluent. 
Fractions were tested for proteins at 280 nm. A large 
peak between 20 to 150 ml was divided into 3 pools and 
tested for N-glycanase activity using transferrin 
deglycosylation as a test. Pools l and 2 showed 
activity, were pooled, concentrated, added to an equal 
volume of glycerol for use with the erythroglycan and the 
rest stored at -20 °C for future use.
Preparation of the neoglycoproteins:
The neoglycoproteins were made according to the 
procedure of Gray94 modified by Roy et al.95 1 umol of
BSA, 300 umol of the sugar and 1.6 mmol of NaCNBH3 were 
dissolved in 5 ml of 0.2 M borate buffer, pH 9.0 and 
incubated at 37 °C for 1 day. After cooling, 80 % H2S04
was added until the pH was 3-4. In some cases, the 
NaCNBH3 and other salts were removed by microdialysis 
overnight. All neoglycoproteins except the erythroglycan 
neoglycoproteins were then chromatographed on a Bio-Gel 
P-2 column (bed volume 100 ml, 1.7 X 45 cm, for the 
chitooligomer neoglycoproteins and bed volume 70 ml, 1.7 
X 30 cm for the maltooligomer neoglycoproteins) in the
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cold using distilled water as an eluent and monitored at 
280 nm for the protein portion of the mixture. 100 ul 
aliquots of the fractions were tested at 490 nm for the 
sugar profile after treating with phenol + H2SC>4, as
shown in figures 8a, 8b and 8c for the glucose (Ml), 
maltotetraose (M4), and maltoheptaose (M7)
neoglycoproteins, respectively. The amino sugars of 
chitooligomeric neoglycoproteins were monitored at 585 nm
Q  A
as described above. The neoglycoprotein positive pools 
(coincident absorbance at 280 and 490/585 nm) were pooled 
and dried by lyophilization. The erythroglycan 
neoglycoprotein was chromatographed on Bio-Gel P-200 
column (bed volume 330 ml, 1.6 X 165 cm), monitored as 
above, and fractions positive for both protein and sugar 
pooled and lyophilized. An extra protein peak observed 
in the EG-NGP profile and eluting around 32 kDa was due 
to the glycanase enzyme. The profiles of chitooligomers 
obtained by enzyme digestion, HC1 digestion, and the C- 
NGP (pool 5) profiles are shown in figures 5a, 5b, and 5c
respectively. The profiles of EG, and EG-NGP (pool 1) 
are shown in figures 6a and 6b respectively.
Gas chromatographic analysis:
Gas chromatographic (GC) analysis for quantifying 
component sugars was performed after methanolysis as the 
tri-methylsily 1 derivatives.84 Briefly, mannitol was
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added as an internal standard to sugar containing 
compounds, the mixture methanolyzed with anhydrous 
methanolic-HCl, re-N-acetylated with acetic anhydride in 
pyridine/methanol, and trimethylsilylated. GC was 
performed on a Perkin-Elmer model Sigma 3 00, using a 
fused silica capillary column, 30 m X 0.25 un (J & W 
Scientific, Folsom, CA), peaks were analyzed using a 
Perkin-Elmer Sigma 15 chromatography data station and 
flame ionization detection. Carrier gas flow rate was 45 
ml/min and a temparature from 140 °C to 240 °C was 
employed.
Inhibition assays using measure of 3H-hypoxanthine 
incorporation into parasites;
This experiment was done as described above in 
experiment one, except that only the SLD6 strain was used 
for the invasion assays. An extra negative control of 
BSA was included for the inhibition studies. BSA does 
not inhibit P. falciparum even at 100 uM 
concentrations. This was confirmed before its use in
actual experiments and inhibition levels of less than 10 
percent of maximum were consistently observed at 
concentrations of 100 uM and less. At higher 
concentrations, there was a steady rise in inhibition 
until 200 uM where 80 % inhibition was observed. Ligands
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that inhibited invasion were effective at concentrations 
well below such levels.
EXPERIMENT THREE 
Metabolic labelling for binding studies:
Metabolic labelling of the parasitized cells was done 
using 35S-methionine.96 The culture was isolated and 
synchronized as described above and then the radiolabel 
was added. The cells were incubated at 37 °c for 30 
minutes. The cells were resuspended in the growth 
media without methionine, supplemented with gentamycin 
and maintained at 37 °c for 2 hours in the presence of 60
n c
ul of J s-methionine, and solubilized in buffer 
containing Tween-20 (T-20).
Affinity chromatography using activated agarose:
EG-activated Sepharose was made as described by March
q n ,
et al. First, erythroglycan was prepared as described
above, chromatographed on a Sephadex G-50 column, 
divided into high, middle and low molecular weight pools 
(HMW, MMW and LMW respectively), corresponding to pools 
1, 2, and 3, as shown in figure 6a. A 2 mg/ml aliquot of 
each pool was dried by lyophilization. To each pool was 
added 3 ml of 0.2 M NaHCO^, pH 9.5 in the cold in a 50 ml 
centrifuge tube with continuous stirring. About 7.5 ml
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of 2 M Na2C03 was added to washed 7.5 ml of a well 
stirred suspension of Sepharose 4B. To this was added 
0.4 ml of CH^CN containing 0.75 g of CNBr. This was 
stirred for 1-2 minutes, filtered on a scintered funnel, 
washed again with 30-40 ml of 0.1 M NaHC03, pH 9.5, then 
with water, and finally with buffer, pH 7.8. The CNBr 
activated Sepharose was then divided into 3 equal parts 
and added to each of the erythroglycan pools above. The 
mixture was washed with 4 ml of NaHC03 and stirred 20 
hours at 4 °C. Unreacted sites on the Sepharose were 
then reacted with 100 ul of ethanolamine at room 
temparature, overnight. Each fraction of the activated 
Sepharose 4B was spun at 200 X g for 5 minutes to obtain 
the erythroglycan affinity columns. Control affinity 
column contained ethanolamine treated Sepharose 4B.
Merozoite protein binding studies:
Binding studies were carried out using a slight 
modification of the method reported by Perkins,46 The 
activated beads were washed twice with 0.1 M P^ buffer, 
pH 7.8 and 400 ul added to an equal volume of PBS 
containing 500 mM amino n-caproic acid and 100 mM 
benzamidine (protease inhibitors). To this was added 65
 ^C
ul of the above JJS-labelled merozoite homogenate in 835 
ul of PBS with protease inhibitors, containing 700 ul of 
0.05 % Tween-20 (T-20) and incubated for two hours on a
nutator at room temparature. The contents were then spun 
on an IEC clinical benchtop centrifuge at the highest 
setting for 3 minutes. The supernatent was transferred 
to centricon micro-concentrators {Amicon Division, 
Danvers, MA), with a 10 kDa cutoff and centrifuged at 
2000 X g for 30 minutes. This procedure was repeated 
twice, each time with the addition of 1 ml of PBS with
inhibitor, T-20 and PMSF. Flow-through from each column
was measured for radioactivity, run on 7.2 % SDS-PAGE and 
detected by autoradiography.
The procedure was repeated with different chemical
treatments to elute bound proteins from the column. Two
ml of 2 M Nal, the first eluent, was incubated with the
column and the cutoff washes collected for measuring
counts and running a PAGE for autoradiography, as above.
*
10 drops of 10 % acetic acid were then added to the 
column until the pH reached 2 and boiled for 5 minutes. 
This was the second eluent. Base treatment was avoided 
because sugar residues are labile to such treatment and 
breakdown of the affinity column would ensue. After 
cooling, the column eluents were analyzed as above. 
Finally, radioactivity remaining in the column was 
measured. The results are shown in table 3, figures 13 
and 14, respectively.
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RESULTS AND DISCUSSION
EXPERIMENT ONE
Standardization studies using different strains:
In the studies described here, care was taken to 
address roost if not all criticisms levelled against 
malaria studies. Pure ligands were used; parasite
strains were synchronized by well-established methods as 
referenced above; standardized procedures were followed 
for culture propagation; fresh red cells not older than a 
week were used for propagation and during invasion
studies; and viability of strains was checked 
periodically by morphological examination of Giemsa- 
stained thin smears.
Figures 9a, 9b, 9c and 9d show the inhibition
profile for invasion of human red cells by four
strains of P. falciparum, FCRK+, FCRK-, PAP (Honduras)
and SLD6 (Sierra Leone), using erythroglycan as a 
ligand. H-hypoxanthine incorporation into the
different cultures was assessed in the absence
(control) and presence (experimental) of various
concentrations of erythroglycan. Since the cell 
harvestor employed for this purpose works by extracting 
radiolabel associated with cell membranes, another
control assessed the amount of radiolabel bound to red 
cells in the absence of the labelled parasite. This 
label was negligible (data not shown) with counts in the 
range of a few 100 cpm (425 cpm maximum), but became 
significant at higher ligand concentrations and were 
subtracted from the readings of all the experimental 
counts. Incorporation of label in red cells in the 
presence of heparin also was negligible, with a maximum 
of 311 cpm. In the presence of different ligand 
concentrations, the maximum label was 350 cpm and was 
appropriately subtracted. Heparin was a positive control 
in these experiments. The malaria invasion hypothesis 
postulates accidental contact of the parasite with 
negatively charged sialic acid residues; heparin, which 
is rich in such negative charges, works as an excellent 
inhibitor of malaria invasion. The profile of heparin 
inhibition was identical in all the strains.
A control for toxicity was included in these studies. 
This type of control was probably reported for the first 
time and differs from the conventional method of checking 
for toxicity. Conventionally, toxicity is tested by 
monitoring the life cycle of the parasite by using thin 
Giemsa stained smears at different time points of the 
assay.48 Observation of the degenaracy of experimental 
parasites to a late ring stage compared to the schizont
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stage of control parasites indicates toxicity. To avoid 
the tedium of such a method a radiolabelling method was 
used. 3H-hypoxanthine incorporation in parasites in 
appropriate ligands was measured during the second life 
cycle and compared with that during the first. The 
rationale was if the ligand were toxic to the parasite, 
the number of successful parasite invasions, if any, 
would be drastically reduced and this number would be 
reflected in the subsequent invasion and growth of the 
parasite. In the absence of toxicity and true 
inhibition, such growth will not be affected and the 
higher burst size would more than compensate for the 
presence of the ligand inhibitor. A lower level of 
percent inhibition will be observed during the second 
life cycle in such cases and arbitrarily, this was set at 
10 % or less.
The percent inhibition of hypoxanthine incorporation
» Q Q
was determined using the following equation:
% Inhibition of Incorporation =
(Incorporation of Controls - Experimentals)
  x 100
Incorporation of Controls
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where the control was label incorporation in the absence 
of any ligands*
The profiles for each strain showed similar behaviour 
with some minor differences. Erythroglycan was a 
strong inhibitor for all the strains, with 
concentrations for half maximal inhibition (1C5Q) in the 
range of 54 to 66 uM. The inhibition curves pleateau to 
a maximum of 95-100 percent inhibition of control at an 
erythroglycan concentration of about 1 mg/ml. Except for 
the PAP strain, the inhibition profile before l mg/ml 
showed a steady, nearly linear increase until the 
pleateau was reached. In the PAP strain, the inhibition 
was not observed until a concentration of 0.68 mg/ml of 
erythroglycan was reached, after which it showed the 
steady increase as in the other strains. Assuming an 
erythroglycan molecular weight distribution of 12 kDa to 
3 kDa, with an average at 10 kDa, the concentration 
showing half maximal inhibition (IC50) of 50 uM (range: 
41 to 167 uM) was the lowest for the SLD6 strain, 
indicating erythroglycan was most potent in that strain. 
This was followed by the FCRK- strain, the FCRK+ strain 
and finally the PAP strain. The IC^q values for the 
strains are given in table 1.
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It was also noteworthy that erythroglycan showed no 
signs of toxicity in any of the strains tested. All the 
second cycle inhibition readings were well below the 
arbitrary 10 % inhibition level. In fact, in all except 
one of the strains (SLD6 ), the toxicity was negative 
ranging from -40 % in PAP and FCRK- to -10 % in FCRK+.
In SLD6 the levels were nearly zero. The heparin
toxicity was around zero in all four cases as expected.
The negative value for toxicity indicates a very high
level of invasion during the second life cycle. If this 
level of invasion is greater than even the level of 
invasion in the control (no ligand) of the first life 
cycle, the percent toxicity will be negative. 
In view of the results discussed above, only one strain, 
SLD6 , was chosen for the parasite protein binding and 
neoglycoprotein inhibition studies.
EXPERIMENT TWO:
One of the rationales for using neoglycoproteins as 
opposed to the free sugars as inhibitors is that the 
conformation of the sugar in the neoglycoprotein form is 
possibly more similar to the in vivo conformation and 
hence amenable to parasite interaction. Indeed, Lee and
QQ , , (
Lee7? reported in 1982, that in many recognition systems, 
carbohydrate containing macromolecules are more efficient
at binding to a receptor than a free sugar itself. In 
1983, Jungery et al.35 reported the first such study in 
the malaria system using N-acetyIglucosmine coupled to 
BSA. However, they used glutaraldehyde as the coupling 
agent. Glutaraldehyde is known to change the properties 
of the proteins being modified.35' 100 Schulman et al.46 
used thioglycosides instead, as coupling agents. 
Conjugation of BSA and sugars by the amidination reaction 
using thioglycosides usually does not affect the tertiary 
structures and biological properties of proteins.^® 
They reported 84-fold inhibition of P. falciparum 
invasion of human red cells with the neoglycoprotein in 
comparison with the free sugar. No other
neoglycoprotein, where the sugar component was mannose, 
fucose, glucose, galactose and N-acetylgalactosamine 
showed any inhibition. However, apart from assaying the 
effects of various neoglycoproteins by monitoring 
parasite stages in control cultures, no other controls 
(such as BSA or heparin) were used. There was no 
mention of toxicity monitoring and it is not certain if 
the apparent inhibition was due to toxicity or other 
artifacts. Though thioglycosides probably do not alter 
protein conformation, and the emphasis of the study was 
prevention of such changes, possible effects of the 
thioglycosides on the parasites were not considered. A
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check for toxicity assumes an extremely important role 
especially considering that even free sugars appear to be 
toxic to parasites.35' 37f 41
In this study an entirely new approach to making 
neoglycoproteins was used. Instead of using conventional 
coupling agents such as glutaraldehyde or thioglycosides, 
whose effect on the parasite protein or carbohydrate is 
unknown, the natural sugar itself was used as a bridge. 
In the reductive amination reaction described above the 
reducing sugar forms a Schiff base with an amino group on 
a lysine side chain. This reduces the number of sugars 
on the neoglycoprotein by one, but when highly polymeric 
sugars are used, such a reduction probably is 
inconsequential. In any case, the reducing sugar is not 
completely lost, but remains in the final form as an open 
chain structure, but with a reduced Schiff base in place 
of the reducing carbon.
As will be discussed in detail below, erythroglycan 
showed maximum inhibition compared with neoglycoproteins 
of other sugars that were tested, and was 10 times more 
effective than the free sugar. Maltooligosaccharides 
showed no appreciable inhibition at all. Chitooligo- 
saccharides were 11 to 68 times more effective as 
neoglycoproteins than as free sugars but were less potent 
than the corresponding erythroglycan sugars.
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Inhibition with maltooligosaccharide neoglyco­
proteins (M-NGP):
Three maltooligosaccharides were used as neoglyco­
proteins and compared with free sugars for their ability 
to inhibit P. falciparum invasion of human red cells, as 
shown in figure 10. These were glucose, maltotetraose 
and maltoheptaose. Glucose would form an open chain 
structure with the BSA in the M-NGP. All the other 
sugars would remain intact except for the sugar at the 
reducing end.
Negligible inhibition was observed in all the three 
cases, with a maximum inhibition not exceeding 10 % of
the positive control. The same was observed for the free 
sugars (data not shown). Also omitted from the graph are 
the negative control curve of BSA inhibition, which falls 
close to the M-NGP and free sugar inhibition profiles. 
Although toxicity was not expected in the absence of 
inhibition, the tests were performed nevertheless. All 
toxicity values were well below the 10 % level (data not 
shown).
Inhibition with chitooligomeric neoglycoproteins (C- 
NGP)
Five pools of chitooligomers were used as 
neoglycoproteins as well as free sugars and tested for
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inhibition of malaria parasite invasion of human red
cells. As seen in figure 11, the free sugar as well as 
C-NGP profile fell well within the positive (heparin) and 
negative (BSA) control. There were two clusters of 
curves in the graph. One of the clusters (the top
cluster) was the free sugar cluster and the bottom one
belongs to the C-NGP. There were no appreciable 
differences within any cluster. If any, the lower 
molecular weight C-NGP (pools 4 and 5) showed a delayed 
inhibition. The differences in the inhibition profile of 
the free sugars were more minor. As such, the clusters 
were treated as a single entity for calculation of 
values.
Initially the inhibition by the free sugars seems to 
be greater than that of the C-NGP. However, since the 
BSA does not play any appreciable role in inhibition at 
the lower concentrations used for the sugars, the IC50 
values must be calculated on the molar basis of the
Q Q
sugars. The IC50 value for the free sugar clusters was 
16.94 uM, while that for the C-NGP cluster was 67.15 uM. 
Since the gel filtration data (confirmed by GC analyses) 
indicated that the chitooligomers range from 10 to l 
sugar residues, the true IC50 for C-NGP on the molar 
basis of sugar would then be 67.15 X (1600 to 250) /
68,000 = 1.58 to 0.25, where 1600, 250 and 68,000 are the
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molecular weights of pool 1 (average), pool 5 (average) 
and BSA respectively. Thus, the chitoneoglycoproteins 
were 11 to 68 times more effective as inhibitors of P. 
falciparum invasion than their corresponding free sugars.
Inhibition with erythroglycan neoglycoproteins (EG-NGP)
Three pools were selected for this part of the study: 
greater than 10 kDa, 10 kDa to 3 kDa and less than 3 kDa 
of erythroglycan. The rationale for choosing this was 
that the greater than 3 kDa cutoff would have pure 
erythroglycan. Although, according to Laine et al.,101 
the cutoff for erythroglycan was set at 5 kDa and more, 
fractions less than 5 kDa are referred to as lower 
molecular weight erythroglycan. Short N-linked sugars 
with a molecular mass less than 3 kDa are present on band 
3, but in a chromatographic profile these would be
contaminated with higher molecular weight ceramides and
Q ftO-linked sugars. The 10 kDa fraction was used to
examine possible effect of size on inhibition. 
Figure 12 shows the inhibition profile of erythroglycan 
in the free as well as the neoglycoprotein form. Heparin
and the toxic controls are excluded from this figure to
avoid overcrowding, but the controls were as expected, 
with negligible percent inhibition of parasite invasion 
of red cells compared with inhibition in positive
controls. The experimental profiles fell within the
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heparin and BSA curves, and the toxic control had 
inhibition values of five percent or less of maximum. The 
profiles of the free as well as the EG-NGP came as 
clusters but there was a marked difference within each 
cluster or pool, precluding the possibility of treating 
them as one entity. On a molar basis of sugars, the IC^q 
values for the EG-NGP were much lower than values for 
free erythroglycan. Table 2 summarizes the results of 
the neoglycoprotein inhibition studies.
Studies done thus far, that use neoglycoprotein as 
inhibitors report IC50 values on the molar basis of the 
sugar (reference 100, for example). However, these 
studies deal with neoglycoproteins involving only one 
sugar residue. This study is probably the first to use 
neoglycoproteins, where the sugar portion was greater 
than a monomer and also served as a coupling agent. 
Hence, in the calculations, an extra step of analysis 
was added that takes this into account. IC5o values were 
reported both on the molar basis of the sugar as well as 
per monosaccharide. The latter value would be more 
appropriate for comparisons among the different sugars 
and the neoglycoproteins, since they have molecular 
weights ranging from 180 to 79,000.
Several features emerged from the comparison of 1C50 
(per monosaccharide) values of the free sugars and their
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neoglycoproteins. Except for the malto series (M and M- 
NGP) where no inhibition was observed, the inhibition by 
neoglycoproteins was many times greater than by the 
corresponding free sugars. Surprisingly, the
chitooligomers were quite effective as neoglycoproteins, 
being 11 to 68 times more potent than the free sugars. 
Erythroglycan as a neoglycoprotein was only 2 to 10 times 
more effective than as the free sugar. As a close 
possible natural receptor, the reverse would have been 
expected. On the other hand, it could also mean that the 
potency of the erythroglycan as an inhibitor was so high 
that it would make little difference (2 to 10 times as 
against 11 to 68 times in the C-NGP's) as to how it was
presented to the parasite. This is probable if the
conformation of the EG sugar in the free form is nearly 
the same as that in the protein bound form.
If comparisons of the IC5Q values were calculated on 
the molar basis of the sugar, the C-NGP's were more 
potent as inhibitors of P. falciparum invasion of human 
red cells than the EG-NGP's. This was followed by the
chitooligomers themselves in the free sugar form and
lastly the erythroglycan pools (except for pool 3 of 
erythroglycan, which was more potent than the 
chitooligomers). However, taking into account the number 
of sugar residues in each pool, and comparing on the
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basis of the IC50 (per monosaccharide), the erythroglycan 
neoglycoproteins were the most potent, with an IC50 value 
ranging from 0.11 (pool l) to 0.30 (pool 3) uM/mono- 
saccharide. This was, followed by the chito- 
neoglycoproteins, free erythroglycan and free
chitooligomers in that order.
In summary, the erythroglycan neoglycoproteins were 
the best inhibitors of parasite invasion, pointing to a 
likelihood of their involvement as a receptor. 
Comparisons of IC^q (per monosaccharide) values within 
pools indicates a higher potency for the higher molecular 
weight erythroglycan neoglycoproteins. This trend was 
also seen in the case of the chitoneoglycoproteins. 
Although the chitoneoglycoproteins were treated as a 
single cluster, on close inspection (as noted above), 
there was a trend for the higher molecular weight pools 
(pools 5 and 6) to have a higher potency for inhibition. 
If the correlation between inhibition and receptor 
function is true, it is likely that the parasite prefers 
higher molecular weight ligands. On the other hand, the 
numbers reflect the ease of accessibility of entry into 
the red cells, since a parasite is more likely to 
encounter a bigger sugar than a smaller one. In the 
case of the free erythroglycan sugars, the trend was 
somewhat different. Pool 3 was most potent, followed by
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pools 1 and then 2. The most likely reason for this is 
that pool 3 contains a large concentration of higher 
molecular weight ceramides, O-linked sugars and possibly 
lower molecular weight erythroglycan. The ceramides 
inhibit parasite invasion by inserting into the parasite 
and red cell membranes, as discussed above. So a 
combined effect of the ceramide and the N- and O-linked 
sugars is reflected in this figure. If the postulate 
about the stronger effect of higher molecular weight 
sugars is correct, and only the molecular weight effects 
on inhibitions are observed, then if other factors are 
held constant, this trend should be seen in the case of 
the erythroglycan. Indeed, the ceramide fraction (and O- 
linked sugars) was lost in the formation of the EG-NGP, 
since N-glycanase was used in the preparation, and only 
pure N-linked sugars were present in the EG-NGP pool 3. 
Cleaned of these other types of sugars, this fraction 
does show a higher ICgQ (per monosaccharide) value and 
the trend of EG-NGP inhibition follows the expected 
pattern of behaviour. The higher molecular weight pool 
was the strongest inhibitor, at 0.11 uM/monosaccharide 
followed by the middle weight range pool 2, at 0.17 
uM/monosaccharide and lastly, the pool 3, devoid of 
ceramides and O-linked sugars, was inhibitory at 0.30 
uM/monosaccharide.
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EXPERIMENT THREE
The results obtained with the binding experiments, 
where 35s-methionine labelled merozoites were passed 
through an erythroglycan activated Sepharose 4B column, 
supported the theory of merozoite proteins binding to the
erythroglycan ligand. As seen in table 3, the counts in
the flow-through were maximum at a level of 450,000 and 
more in each of the three cases of affinity ligands made 
with the low, middle and high molecular weight 
erythroglycan pools (LMW, MMW and HMW respectively). 
These values were at least ten times more than the counts 
obtained with the Nal elution of the proteins, where the
next level of maximum counts was obtained. In fact, the
bound parasite proteins would be expected to elute in 
this wash. The flow-through readings contained unbound 
proteins as well as excess label. The control showed 
about 20 percent of the label sticking to the Sepharose 
4B column, but no siginificant amount of the label eluted 
with Nal or the acid treatment. This points to the fact 
that labels that eluted out with these treatments in the 
experimentals were associated with the affinity ligand: 
erythroglycan. These columns did have non-specific 
binding to the Sepharose columns, that showed 20-30 % of 
the labels associated with the beads and did not elute 
with the chemical treatments. This could be due to
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incomplete reaction with ethanolamine or precipitation of 
proteins in the column during acid treatment. The MMW 
erythroglycan however, showed negligible non-specific 
binding, where less than 1 % of the label was associated 
with the beads. The reason for this is not known. 
Probably, more erythroglycan or ethanolamine was bound to 
the column and no site on the affinity column was 
available for such non-specific binding. Among the 
chemical treatments, most counts eluted out during the 
Nal treatment. The MMW ligand affinity column showed 
maximum binding among the columns, though it is not known 
if this was due to the higher level of MMW ligand on the 
column, alluded to above. This was followed by the LMW 
and finally, the HMW associated label.
Proteins greater than 10 kDa molecular weight were 
associated with the most ligand bound label and this 
level was 3 (in the case of MMW ligand) to 12 (in the 
case of HMW ligand) times more than the bound proteins 
that weighed less than 10 kDa. Whether this is just a 
reflection of the sizes of the proteins, rather than the 
level of binding affinity will be impossible to answer. 
In any case, since most outer membrane proteins on the 
parasite that are mentioned so far are greater than 10 
kDa in molecular weight,21 the discussion will be 
confined to the >10 kDa proteins. Less than l % label
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was eluted in the acid treatment of the beads. Figure 13 
illustrates the results of table 3.
Figure 14 shows the autoradiographs of the labelled 
bound and unbound merozoite proteins, after running on a 
7.2 % SDS-PAGE gels. The flow-through in the control
shows the complete profile of the merozoite proteins. 
The flow-through from the LMW, MMW and HMW affinity 
columns shows nearly the same profile, except for the 
absence or diminution of some protein bands compared with 
the bands from the other washes. Prominent among these 
were two high molecular weight bands that eluted out 
during the Nal elution step, in all the three columns. 
The Nal profile shows two prominent bands at 118 kDa and 
another one at greater than 200 kDa, associated with the 
LMW, MMW and HMW ligand. It is not known if the latter 
(>200 kDa band) corresponds to one or more proteins. For 
some reason, the >200 kDa band associated with the LMW 
and HMW column did not elute out completely in the Nal 
treatment and the rest of the protein was eluted out in 
the acid treatment (more in the former treatment). The 
118 kDa and >200 kDa proteins associated with the MMW 
ligands elute in one step of Nal treatment and no bands 
were observed in the acid treatment of this column. The 
Nal and acid eluent autoradiographs were purposely 
overexposed to compensate for the reduced radioactivity.
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These binding studies point to the high affinity 
binding of 118 and >200 kDa proteins of the merozoite to 
erythroglycan. These were most likely outer membrane 
proteins and the >200 kDa protein could be the same 
protein (Pf2 00) that is said to interact with 
glycophorin, and is discussed below. The 118 kDa protein 
is a newly reported protein associated with the 
merozoite and is very likely a new candidate receptor of 
the parasite that specifically binds erythroglycan.
No differences in the amount of the parasite 
attachment was observed with respect to the sizes of the 
ligand. Except for the two stage elution of one of the 
proteins associated with the LMW and HMW ligands, there 
were no differences in the protein profiles of the three 
ligands. On close examination, however, the proteins 
associated with the HMW ligand seemed to be fainter than 
the ones associated with the LMW and MMW ligands except 
for the 118 kDa protein associated with the LMW ligand, 
which was the faintest. This was probably because the 
MMW and LMW fractions contain N-linked, O-linked sugars 
and also ceramides. The combined effects of each was 
discussed in detail above. The 118 kDa protein seems to 
be interacting more with the lower molecular weight 
sugars than it does with the higher molecular weight 
fractions. This may seem contradictory to the above
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observation of greater interaction of parasites with the 
higher molecular weight fractions of erythroglycan. 
However, in the absence of affinities calculated on the 
molar basis of sugar or per monosaccharide, no such 
conclusion can be drawn. The quantitative affinity for 
the different pools will be difficult to assess in the 
absence of densitometric studies and also because of the 
many variables used in the binding studies. In light of 
this, such assessment is best left to quantitative 
studies done with inhibition assays and was discussed in 
detail above. Lastly, the differential involvement of 
proteins for different ligands has been reported 
before.21
It would be pertinent to point out possible future 
work, of aspects of some the work outlined above. A more 
standardized approach could be used to detect the 
parasite proteins that interact with the erythroglycan 
columns. Elution with erythroglycan would be more 
appropriate as a first step elution, rather than using 
Nal, as is conventionally done. This would most likely 
ensure the elution of most parasite proteins. The 
retention of much of the radiolabel even after the acid 
wash step could have been diminished by such a treatment. 
Also, it would be impossible to eliminate completely the 
radiolabel retention.
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In conclusion, examination of the most recent 
reviews that deal with the biochemical nature of the 
invasion of malaria parasite into human red blood cells, 
impresses one with the complexity and variable nature of 
the process.21' 35' 1°2“1°6
The initial involvement of glycophorin was very 
strongly suggested by the inhibition studies with whole 
or different fragments of glycophorin.23, 2 '^ 33-37, 42,
46, 47 Also important were the studies with human red
cells with defects in glycophorin.9, 22, 38~41, 44, 45
However, several contradictory results were reported and 
the one receptor theory had to be discarded.48' 50-55 
The reason glycophorin cannot be discounted as a receptor 
altogether, is because of the critical requirement of 
sialic acids for invasion. This points to the likely 
involvement of negatively charged sialic acids in the 
initial contact with the parasites, the first step in 
invasion.9 In cases where normal invasion was observed 
in glycophorin or sialic acid deficient cells, the likely 
explanation is strain variability caused by evolutionary 
pressures and this has been reviewed in detail by
O 1
Perkins. A Also, two receptors in the parasite are said 
to be involved in the invasion. These are the Pf200 (or 
gpl95) and a 175 kDa protein. In most cases the Pf200 
takes an active role in invasion. The other one may be
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involved in non-sialic acid dependent invasion. Thus, 
glycophorin appears to direct the invasion by presenting 
charged sialic acid residues to parasites in the blood 
stream. At least the Pf200 protein must contain 
localized positive charges that could interact with the 
sialic acid residues. This explains why other ligands 
possessing dense negative charges inhibit the parasite. 
Thus, heparin, sulfated polysaccharides, and glycosamino- 
glycans block the receptor mediated invasion of 
erythrocytes.107 To account for all these observations, 
a multi-receptor mode of invasion was envisioned.63
The next candidate receptor of choice was band 3. 
Several evidences were responsible for this choice. Band 
3 in liposomes66 and band 3 glycopeptides67 inhibited P. 
falciparum invasion. Other related observations may 
indicate the importance of band 3 in such an invasion. 
Rhesus monoclonal antibodies inhibit one of the late 
stages of P. knowlesi invasion of rhesus erythrocytes, a 
system close to the human.72 Very recently, the high 
affinity binding of P. falciparum merozoite polypeptides
O 1
to band 3 was reported. At the time of this writing, 
the report was not available and the details are awaited. 
The results however, seem to be similar to those in this 
study. Binding of at least two parasite proteins was 
observed by affinity chromatography on erythroglycan
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activated Sepharose 4B. One of these, the >200 kDa 
proteinfs) may be the same as the one involved in 
glycophorin recognition. More than one protein could be 
involved here as it was part of the immobile protein band 
on an SDS-PAGE. Also observed, and for the first time, 
was the 118 kDa protein, that may be specific for the 
erythroglycan interaction.
No quantitative information could be obtained from 
the gels above, regarding the differential interaction of 
the proteins with respect to the erythroglycan. However, 
inhibition assays indicated stronger interaction with the 
higher molecular weight fractions. This agrees with the 
observations of Friedman et al. that higher molecular 
weight glycopeptides of erythroglycan inhibit P. 
falciparum better than lower molecular weight 
fractions.67 The inhibition in this study was strongest 
with erythroglycan neoglycoproteins and was in the 
micromolar range. This does not compare favorably with 
Okoye et al.'s observation where nanomolar levels of 
inhibition were observed.66 But Okoye used pure band 3 
embedded in liposomes, which was the closest bio-mimic 
that was available for the system.
The use of BSA neoglycoproteins in this study 
precluded the need to purify band 3, even though the
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purification is a simple two step process involving DEAE- 
cellulose108 and [{p-(chloromercuri)benzamido}ethyl]-
1 O Q *agarose 4B gel^”  chromatographies. This was due to the
extreme insolubility of band 3 in aqueous media.
However, good results were obtained with BSA-
erythroglycan neoglycoproteins, with inhibition levels in
the uM range for all the pools studied. No differences
were observed in the inhibition profiles in four
different strains of P. falciparum and the results may be
said to be generally applicable to the parasite, but with
caution. Just as in the case of glycophorin,
erythroglycan like carbohydrates can substitute for
erythroglycan, and fibronectin inhibits P. falciparum 
7  flinvasion.
In summary, P. falciparum can be said to invade human 
red cells via a first step involving an ionic 
interaction. This is followed by information transfer to 
the red cell cytoskeleton proteins 4.1 and spectrin, or 
through band 3 to spectrin via ankyrin. Band 4.1 
promotes association between spectrin and actin and is 
pivotal in the assembly of the membrane skeleton. A 
crucial membrane deformation follows, in the absence of 
which, no invasion takes place. This induces the 
reorientation and the apical attachment of the parasite, 
followed by a zipper-like action. The latter would need
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high affinity binding, and the lectin-like interactions 
afforded by parasite proteins and erythroglycan are well 
suited for such. Thus, again affecting the additional 
associations of band 3 amino terminus with cytoskeletal 
proteins, the parasite enhances the fluidity of the red 
cell membrane, a prerequisite for invagination of the 
host cell. This completes the receptor mediated 
endocytosis of P. falciparum into human red blood cells.
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Table 1. Concentration of erythroglycan for half maximal 
inhibition, Icso' Plasmodium falciparum invasion of 
human red blood cells in four different strains.
IC50 uMa
Strain Range Average
FCRK+ 60-237 54
FCRK- 52-207 47
SLD6 41-167 38
PAP 74-293 66
a - Calculated from data of figures 7a-d, and are mean of 
three independent preparations.
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Table 2. IC50 values for M-NGP's, C-NGP's and EG-NGP's 
and their free sugars.
Specimen Molecular
weight*
1 C „  U « b
(On mo I a r basis 
of the sugar)
1C50 u" b 
(Per mono-
tacchar ide)
Ratio 
Free sugar 1C ^ Q/ 
NCP IC5Q
EC Pool 1 11,000 69.10 1.15
EC Pool. 2 6,500 58.46 1.67
EC Pool. 3 1,600 15.00 0.60
EG-NGP Pool 1 79,000 6.52 0.11 10
EG-NCP Pool 2 74,500 5.80 0.17 10
EG-NGP Pool 3 69,600 2.69 0.30 2
C Pool 1 1,600
C Pool 2 1,200
C Pool 3 900 16.94* 3.76*
C Pool 4 600
C Pool 5 250
C-NGP Pool 1 69,600
C-NGP Pool 2 69,200
C-NGP Pool 3 68,900 1.58 to 0.25* 0.20 to 0.30* 11 to 68
C-NGP Pool 4 68,600
C-NGP Pool 5 68,250
HI 180 c
M4 666 c
M 7 1,152 c
H1-NGP 68,180 c
N4-NGP 68,666 c
M7-NGP 69,152 c
* Average values are given for pools and clusters.
^ Calculated from data of figures 6. 9 and 10 and are mean of 3
i ndependent preparat i ons.
c Less than IS X (of control) inhibition at 100 iM.
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Table 3. Counts (cpm) obtained from 35S-methionine 
labelled merozoite proteins interacting with low (LMW), 
middle (MMW) and high (HMW) molecular weight 
erythroglycan affinity columns and eluted with Nal and 
acetic acid. Unbound proteins are indicated in 
flowthrough, and final counts remaining in column are 
given under Sepharose beads. Proteins are specified as 
weighing less than (<) and greater than (>) 10 kDa.
Treatment Counts® cpm
LMW MMW HMW
Control
Control
Control
Control
flow through 
Nal eluent 
acid eluent 
Sepharose
650,075 
498 
2 11 
121,154
650,075 
498 
211 
121 , 154
650,075 
498 
211 
12 1, 154
<10 kDa 
>10 kDa
flow-through 
flow-through
90,945 
348,516
95,412 
562,164
135,855 
434 , 520
<10 kDa 
>10 kDa
Nal elute 
Nal elute
5, 328 
26,370
13,428 
39,690
2 , 052 
24,450
<10 kDa 
>10 kDa
acid elute 
acid elute
1 , 150 
3 ,720
1 , 325 
4 , 320
1 , 200 
3 , 060
Sepharose beads 244,562 3 ,700 117,726
Total (Experimentals) 720,591 720,039 718,863
aDue to limitations of availability of parasite proteins, 
only one reading was obtained for each set of this 
experiment.
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Figure 1. Structures of sugar chains on glycophorin A.
(a) O-linked sugar chain (b) N-linked sugar chain.
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F i g u r e  2 .  Bio-Gel P-10 profile of erythroglycan prepared 
by pronase digestion of delipidated red cell membranes.
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(5 mM P^ buffer, pH 7.4)
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Figure 3. Flow-chart for the preparation of
erythroglycan glycopeptides from human red cells.
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Figure 4. TLC profile of chitooligomers obtained by (a 
chitinase and (b) HC1 digestion and using eluent 
CH3CN:H20 = 4 : 1
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Figure 7. Site of cleavage of N-Glycanase with 
erythroglycan glycopeptide as substrate.
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Figure 9. Inhibition of P. falciparum by erythroglycan
using (c) PAP and (d) SLD6 strains. Curve passes through
mean of three replicate readings.
of 
3H
-H
yp
ox
an
th
ln
e 
In
co
rp
or
at
io
n
81
1 0 0
□ Heparin 
•  M1-NGP 
■ M4-NGP
80 -
60 -
4 0 -
20 -
c
0 - b
20
1 2 01 0 08 06 04 0
Concentration of M-NGP, uM
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Figure 11. Inhibition of P. falciparum by chitooligomers 
(C) and chitooligomeric neoglycoproteins (C-NGP). Curve 
passes through mean of three replicate readings.
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Figure 13. Counts from 35s-methionine labelled merozoite 
proteins, of molecular weights less than (<) and greater 
than (>) 10 kDa and bound to low (L) , middle (M) and 
high (H) molecular weight erythroglycan affinity columns, 
later eluted with Nal and acetic acid (AA) treatments.
Figure 14. Autoradiographs of 3^S-methionine labelled 
merozoite proteins run on SDS-PAGE after erythroglycan 
(EG) affinity chromatography. (a) flow through, (b) 
bound proteins eluted with Nal (c) bound proteins eluted 
with acetic acid. Lane 1, control; lanes 2-4, proteins 
eluting through low, middle and high molecular weight EG 
affinity columns, respectively; lane 5, MW standards.
CHAPTER 2. REDUCED INVASION OF PLASMODIUM 
MALARIA IN HEMPAS ERYTHROCYTES.
FALCIPARUM
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INTRODUCTION
The invasion of Plasmodium falciparum malaria into 
human red blood cells is through receptor mediated 
endocytosis.10 Due to the diversities in strains of P . 
falciparum, their cross reactivities with hosts, 
developments of resistant strains and evolutionary and 
immune pressures the biochemical nature of the invasion 
is extremely complex. However, over the last decade, the 
mechanism of invasion is slowly being unravelled.
Glycophorin on human red cells was the first 
candidate receptor reported to inhibit P. falciparum 
growth in vitro.23, 33 This was later duplicated by 
several research groups, working with various fragments 
of glycophorin26' 34-3 7 Qr re(j cells deficient in or
lacking normal glycophorin.9 ' 22' 38-41, 44, 45 These
studies also helped in determining regions in glycophorin 
that were responsible for interaction with parasite. It 
was apparent that sialic acids were crucial for invasion. 
Several contradictory observations were also reported 
regarding the role of glycophorin.48' 50-55 The most 
important one was the observation of normal invasion in 
MkMk erythrocytes.56 These cells lack glycophorin A and 
B, and the low levels of glycophorin C levels present 
could not explain the normal level of invasion. These
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contradictions were explained on the basis of strain 
variability or the two receptor theory.21 The two 
receptor theory postulates the involvement of two sites 
of interaction on glycophorin (and two on the parasite), 
with the glycophorin independent receptor probably 
responsible for the contradictory results. This theory 
was rejected by Hermentin et a l .48 due to toxicity 
problems associated with one of the sites on glycophorin. 
In light of such observations, it was necessary to look 
for another receptor and associate the role of 
glycophorin with initial contact of positively charged 
parasite proteins with negatively charged sialic acid 
residues.
Preliminary studies with band 3 proved to be 
promising.66, 67 These studies showed high level of 
inhibition of P. falciparum invasion of erythrocytes with 
band 3. The carbohydrate portion of band 3, 
erythroglycan, especially the higher molecular weight 
fractions were most effective in inhibition. The 
involvement of band 3 in the invasion is suggested to be 
in one of the subsequent steps after the initial 
contact with sialic acids of glycophorin. This is most 
likely a lectin-ligand interaction, a strong and specific 
interaction that is needed for the zipper-like entry of 
the parasite into red cell membrane prior to
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invagination.9 This observation explains the non- 
requirement of sialic acids in assays having band 3 or 
erythroglycan. The accidental step is precluded as the 
parasite can interact with the high affinity receptor and 
find a "short cut" into the red cell.
The malaria studies with red cells defective in band 
3 are just beginning. In the event of parasite protein 
and band 3 interaction, prior to invasion, the growth of 
the parasite in cells defective in band 3 will be 
affected. To test this suggestion, erthrocyte cells from 
a HEMPAS patient were studied for malaria infectivity 
quantifying both radiolabelled hypoxanthine incorporation 
and parasitemia.
HEMPAS is an autososmal recessive form of congenital 
dyserythropoietic anemia, characterized by ineffective 
erythropoiesis.111 Erythroblasts contain two or more 
nuclei indicating defective cell division and an 
inability to expel the nuclei. The biochemical defects in 
HEMPAS patients were reported by Fukuda et a l .112 and 
these were reported to possess truncated band 3 
carbohydrate. The N-linked glycopeptides on HEMPAS 
reticulocyte microsomes contained shorter oligosaccharide 
chains compared with those on normal reticulocytes. The 
synthesis of polylactosamines on HEMPAS cells is
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predominantly stopped at the octasaccharide stage. The 
glycolipid portion of the cells were longer than normal. 
However, a HEMPAS variant showed both truncated glyco­
protein as well as glycolipid. These defects are due to 
the decreased level of various glycosyltransferases. The 
purpose of the present investigation is to study the 
behaviour of the invasion of P. falciparum into HEMPAS 
cells.
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MATERIALS AND METHODS
HEMPAS blood. HEMPAS blood was obtained from Dr. 
Kenneth H. Schumak of the Department of Medicine,
University of Toronto, Toronto, Canada M5S1A8.
P. falciparum culture. A chloroquine resistant
Sierra Leone strain (SLD6 ) was obtained from Dr. Phuc 
Nguyen-Dinh of Division of Parasitic Diseases, Centers 
for Disease Control, Atlanta, Georgia. The culture was 
maintained in continuous in vitro conditions according to
Q C
the method of Trager W. and Jensen J. B. . The culture 
was synchronised with D-Mannitol according to the method 
of Lambros C. and Vanderberg J. P .87 This was followed
> , Q Q
by trypsin treatment of the cells according to Breuer. 
The parasites were synchronized one final time by the 
gelatin sedimentation technique of Jensen, just before an
1 1 K
experiment.
Giemsa Staining. Parasite growth was monitored by 
the morphological evaluation of Giemsa stained thin 
smears made during each four hour time interval.48 
Percent infectivity, and percent ring, trophozoite, 
schizont and segmentor stage parasites were measured by 
counting 1000 red cells per slide.
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Invasion and growth assays. The synchronized culture 
was diluted 1:20 with normal or HEMPAS blood to give an 
infectivity not greater than 1 %. 100 ul aliquots of
cells, in triplicate, with about 1 % parasitemia, were 
then added to 96-well microtiter plates. 3H-hypoxanthine 
(ICN Biochemicals, Irvine, CA) incorporation into 
parasites in normal and HEMPAS cells was monitored as a 
measure of the level of invasion of P. falciparum into 
human red blood cells. 50 ul of 10 uCi/ml of the label 
was added to the wells every four hours. Cells incubated 
for the four period were harvested using Titertekr cell 
harvester (530/550 of Flow laboratories, Ayrshire, 
Scotland) and counts measured on a Beckman LS 250 
scintillation counting instrument. This was done for a 
period of 6 days to cover three life cycles of the 
parasite. Hemolysis, determined according to Dacie, J. 
V. and Lewis, S. M. 116 signalled the termination of the 
experiment. Fresh media was carefully added every 2 days 
to replace an equal amount of spent media, and prevent 
artifacts due to a lack of nutritional status. Label 
associated with red cells was determined by washing 
labelled cells three times with malaria wash and then 
measuring the total label associated with uninfected 
HEMPAS and control cells. The counts were plotted 
against time, such that the zero hour reading in the
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plots corresponded to the beginning of the first life 
cycle or day 1 .
Biochemical Analysis of Normal and HEMPAS Red Blood 
cells. Membranes were obtained from normal and HEMPAS 
cells by the method of Dodge et a l .,82 by hemolysis. 
Small glycolipids and gangliosides were separated by the
O') t
method of Krusius et al., by extraction in chloroform 
and methanol, and lipid free membrane was hydrazinolyzed 
at 100 °C overnight117, 118 and re-N-acetylated with 
■^H-acetic anhydride.119 The glycopeptides were then 
dissolved in 100 mM pyridine-acetic acid buffer, pH 5 and 
applied on a Sephadex G-50 column, bed volume 9.3 ml (0.8 
X 18.5 cm) and eluted with 100 mM pyridine-acetic acid 
buffer, pH 5. 100 ul fractions were collected and
radioactive fractions analyzed for the polysaccharide 
profile.
Lipid fraction obtained in the chloroform/methanol 
extraction was concentrated on a rotary evaporator, S u l  
of which was run on a silica gel TLC plate (Analtech, 
Newark, DE), developed with CHCl^:CH^OH:H20 = 60:35:8,
and the sugars visualized by orcinol:H2S04 reagent.85 A 
part of the extracted fraction was dried, treated with 
ceramide glycanase120 and applied to a Bio-Gel P-4 
column, bed volume 9.0 ml (0.8 X 18.0 cm), eluted with
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100 mM pyridine-acetic acid buffer, pH 5, and sugars 
detected as above, with orcinol-H2S04.
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RESULTS AND DISCUSSION
Growth of P. falciparum: Figure 15 shows the
infectivity or growth profile of P. falciparum in normal 
and HEMPAS cells and during the first 10 hours of the
second life cycle, no difference in the infectivity 
profile of the parasite was noticeable. Also, quite 
expectedly, no difference in the growth was observed in 
the first life cycle, because the parasite was still in 
the stock normal blood (data not shown). After that 
time, the infectivity of the parasite in the normal cells 
was seen to continuously increase till the end of the 
second life cycle after which period the infectivity 
profiles in both cases tapered and showed a plateau. 
For the third life cycle, the growth picked seemed to 
recover, but the experiment was terminated before the end 
of the third life cycle. Results during the third life 
cycle were considered unreliable due to lysis of both 
normal and HEMPAS cells (data not shown). The
infectivity peaked in both the cell types at around 50
hours and was lower in the HEMPAS cells by about 30 %.
P. falciparum invasion: 3H-hypoxanthine incorporation 
or invasion profile shown in figure 16, indicates no 
appreciable difference during the first life cycle in the 
normal and HEMPAS cells. However, close to the start of
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the second life cycle the incorporation steadily 
increased for the parasites in both the cells, showing a 
peak at about 55 hours and then dropped as in the growth 
profile above. The parasite invasion peak in the HEMPAS 
was about 30 % lower compared to the one in the normal 
invasion, throughout the second life cycle. A peak at 
around 90 hours was the appearance of mis-synchronization 
due to a small parasite population. The third life cycle 
showed essentially the same profile where the invasion in 
HEMPAS cells was lower. Since hemolysis set in during 
the third life cycle, as mentioned above, the experiment 
was terminated before the end of the third life cycle 
(data not shown). The experiment, showed 50 % decreased 
label incorporation in the third life cycle than in the 
second.
Giemsa Staining: The Giemsa staining was used for
quantifying growth, results of which are given above. It 
was also used for the morphological evaluation of the 
parasite at various stages of growth. Figure 17 
illustrates the results. Comparison of the percent ring, 
trophozoite, schizont and segmentor stage parasites 
between the normal and HEMPAS cells showed no appreciable 
difference.
Structural Differences: The Bio-Gel P-10 profile of
the carbohydrate portions of normal and HEMPAS cells
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showed expected results.112, 11:^ ' 114 Most of the sugars
of the normal cells, or erythroglycan, voided at 10 
kDa,100 the rest trailing till the point of inclusion, as 
shown in figure 18. The HEMPAS cell carbohydrate profile 
was drastically different, with most of the sugars 
eluting around the inclusion volume corresponding to 
molecular weight of about 1,5 kDa. A wide bulge, most of 
this elutes in the range of 1.7 kDa to 1.6 kDa.
The lipid profile, shown in figure 19, indicated no 
difference on the TLC, with one prominent smear in the 
middle of the plate for both the normal and HEMPAS 
lipids. A long, thin trail at the origin was also 
observed in both the cases, and lastly, a faint trail 
above the prominent middle spot was present in normal as 
well as the HEMPAS lipids.
Finally, the Bio-Gel P-4 profile shown in figure 20 
for the ceramidase treated lipids of the normal and 
HEMPAS cells was identical for both, where sugars ranging 
from 1.2 kDa to the inclusion molecular weight of 0.8 kDa 
(and less) eluted out. This section ends the detailing 
of the results of invasion studies of P. falciparum in 
human red cells abnormal in erythroglycan. The 
discussion and explanation of the observations follow.
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Appreciable amount of difference of the parasite 
behaviour in the normal versus HEMPAS cells was observed 
in both the growth {figure 15) and invasion (figure 16) 
curves. The radiolabelled hypoxanthine incorporation was 
30 % less in the HEMPAS than in the normal cells. The
parasite starts out in the normal cell in the first life 
cycle (at time = 0 hours) and at 48 hours, enters either 
the normal cells or the HEMPAS cells with a 1:20 
dilution. Correcting for dilution effects, the decrease 
would most likely have been greater than 30 %. This same 
degree of reduction was observed in the third life cycle 
(data not shown). The level of incorporation in the 
third life cycle was lesser than in the second and this 
was expected. At or after 2 % parasitemia, the culture 
needs to be diluted. Since it would be impossible to 
dilute several cultures in the 96 well microtiter plates, 
without affecting the variabilities in the results, the 
cultures were left untouched and all conclusions drawn 
from the second life cycle. But, the trend was 
maintained in the third life cycle and that was 
interesting.
The growth curve paralleled the invasion curve. This 
suggests that the growth was most likely a consequence of 
only the invasion, with no other abnormalities, such as
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secondary metabolic disruption, cytoskeletal or other 
defects, encountered during the growth. If in addition, 
the N-terminus or the cytosolic portion of band 3 was 
affected due to the HEMPAS condition, the growth curve 
would be very different from the invasion profile *
Hence, the biochemical defect is manifest on the side 
of band 3 which is outside the cell and which carries the 
carbohydrates.84' 112 Er y thr og lycan, especially the 
higher molecular weight fraction is postulated to be the 
site of interaction of parasite proteins, through 
inhibition assays67 and binding studies.121 indeed, the 
structural studies undertaken to confirm the differences 
in the two cell types, showed the carbohydrate profile of 
the HEMPAS cells to correspond to the lower molecular 
weight region of polylactosamines (figure 18). They 
primarily eluted around the octasaccharide region of 
the gel filtration column. Such N-linked sugars are 
predominantly accumulated in the HEMPAS red cells and no 
higher sugars are found.112' 111' 114 These sugars are 
present on band 3 and band 4.2, but predominantly band 3 
carries two-thirds of such determinants.84 Due to the 
presence of small N-linked sugars, the invasion in the 
HEMPAS cells was not completely affected. In the absence 
of any knowledge of stoichiometry of interaction of 
parasite proteins and ligands on red cells, a
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quantitative correlation between the level of invasion 
and amount of carbohydrate would be impossible.
HEMPAS is caused by the diminution of different 
glycosylhydrolases in patients. Most of the cases of 
HEMPAS condition show, besides a truncated erythroglycan,
7 to 9 times more accumulation of polylactosaminy1- 
ceramides.112' 113 However, a different lipid profile
was obtained from a non-typical variant.13-4 The 
erythroglycan was truncated but the expected accumulation 
of polylactosaminylceramides was not present. Among the 
two reported types of HEMPAS, the patient in this 
study was found to be of the latter variant. The lipid 
profiles {figures 19 and 2 0) of the normal and the HEMPAS 
pateint were identical in most respects. The TLC profile 
showed a prominent smear in the middle of the plate which 
were most likely mixtures of mono- to polyglycosy1- 
ceramides, with the biggest lipid, a tetraglycosyl- 
ceramide. A less prominent smear near the origin and one 
near the top of the plate prompted the gel filtration 
profiles of the lipids, which was done after treating the 
lipid mixture with ceramide-glycanase. The intensity of 
these smears appeared different in the two profiles, but 
it could be due to differences in the handling of the two 
preparations, though utmost care was taken to maintain 
exact conditions of preparations for the two cell types.
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However, no differences were observed in the Bio-Gel P-4 
gel filtration profiles {figure 20) of the ceramidase 
treated fractions of the lipids of the two blood types.
This was fortunate for this study, because the
accumulation of higher polylactosminylceramide found in 
the typical variants of HEMPAS patients could have 
compensated for the lack of polylactosaminylglycoprotein 
on band 3. Though the presence of proteins was a 
requirement for parasite interaction, the erythroglycan 
by itself was not in any way a less potent inhibitor of
P. falciparum invasion of red cells.121 Using this
argument, one would expect polylactosaminyleeramides to 
be as good a receptor of P. falciparum as other N-linked 
or erythroglycan-like free sugars.
Thus, there is a strong correlation between the lack 
of erythroglycan structure and the reduced invasion of
HEMPAS cells. However, there was the likelihood of 
other factors affecting the parasite in the abnormal 
cells and this has to be addressed. For this reason, the 
morphological evaluation on Giemsa-stained thin smears of 
the parasite at various stages was done (figure 17). Any 
adverse effect due to an unnatural environment, was 
reported to cause the parasites to develop to a 
degenerated ring or at most the trophozoite stage, when
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control cells developed to the early schizont stage. No 
such decay was observed for the parasites in HEMPAS 
cells, indicating the environment was not in any way 
adverse to the growth conditions for the parasite. The 
percent ring, trophozoite, schizont and segmentor stage 
parasites in HEMPAS cells paralleled those in normal 
cells and no decay was observed.
No significant differences were observed in the 
radiolabel association with the two control cell types 
(in the absence of the parasite) nor was the level of the 
label significant. The radioactivity was thus totally 
associated with parasite uptake.
It would be relevant to mention here the observation 
of normal invasion and growth by Schulman et a l .110 in 
band 3 structural variants that cause hereditary 
spherocytosis. This is easily explained. Hereditary 
spherocytosis is a genetic defect caused by cytoskeletal 
abnormalities. This is most likely due to defects in the 
cytosolic portion of band 3. This region can reduce or 
eliminate invasion if the band 3 interaction with other 
cytoskeletal proteins is changed in such a way that the 
red cell deformability, a prerequisite for invasion, is 
adversely affected. This is observed in ovalocytosis, 
where a defect in the N-terminus (cytosolic) portion of
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band 3, prevents red cell deformation and makes such 
cells refractory to malaria i n v a s i o n . H o w e v e r ,  there 
are other mechanisms of deformations, independent of band 
3 and involving glycophorin and band 4.1. So if the 
defect in band 3 is not too drastic to affect the other 
mechanisms of deformation, the parasite growth and 
invasion can be expected to be normal. It is very 
likely that this is precisely what is happening in 
hereditary spherocytosis. However, in the absence of any 
detailed biochemical study on such cells, the treatment 
of the observation here can at best be speculative.
The argument by the authors that band 3 is not
required for the parasite development and is proteolyzed
by it121 is untenable. First of all, the level of
proteolysis is not mentioned, which if low, could leave
many more band 3 available for parasite interaction.
Secondly, proteolysis of band 3 by a growing parasite
would occur in the cytosol. This would leave the plasma
portion of band 3 normal and intact for recognition by
invading parasites. Such cytosolically proteolyzed band 3
would not be recognized by anti-band 3 antibodies that
* 71remove senescent cells from circulation. Also, red
cells do not possess the turnover mechanism to replace 
defective proteins. Lastly, band 3 is well anchored in 
the red cell membrane and there is no reason to expect
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a cytosolically proteolyzed band 3 to detach from it. 
Thus, the level of band 3 in such systems would remain 
intact, and the plasma portion would always be available 
for various interactions.
The presence of truncated sugars on band 4.2 of 
HEMPAS patients was also observed112' 113' 114 and needs
to be addressed. Since most of the high molecular weight 
sugars are on erythroglycan,101 the likely effect of band
4.2 would be minimal. It would be interesting to test 
the outcome of an invasion assay of P. falciparum in 
red cells of patients with Coombs hemolytic anemia. This 
is a defect associated with the absence of band 4.2. An 
in vitro assay would establish the involvement of band 3 
in the invasion process of p. falciparum in human red 
cells. It would be pertinent to point out here that the 
substitution of polylactosamines from other proteins does 
not alter the invasion profile of P. falciparum. 
Fibronectin, which has similar polylactosamine chains as 
band 3, shows normal invasion with P. falciparum.78 Band
4.2 possesses high molecular weight polylactosamines but 
not to the extent they are present on band 3.
In light of the above observations and discussion, 
the only biochemical difference between normal and a 
variant HEMPAS cell was the presence of a short
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glycan chain on band 3. The observation of reduced 
invasion in such cells indicated the requirement of the 
long glycan chain on band 3 for successful invasion. 
These observations support other studies that suggest the 
interaction of band 3, 66 and specifically the 
erythroglycan portion 67» 121 for parasite interaction.
Since a lectin-like interaction is postulated in this 
stage of parasite entry,35 the interaction of one or more 
parasite proteins with erythroglycan is suggested. 
Indeed, in binding experiments done in this laboratory, 
at least two parasite proteins (>200 kDa and 118 kDa) 
were observed to bind higher molecular weight fractions 
of erythroglycan on an affinity column.121 A recent 
report of Jones G. L. and Edmundson H. M .^1 of binding 
of parasite proteins to band 3 vindicates our theory.
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Figure 15. Growth of P. falciparum in normal and HEMPAS
human red blood cells in culture. Curve passes through
mean of three independent counts.
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Figure 19. Thin layer chromatography of lipids from
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CHAPTER 3. LINKAGE POSITION AND COMPLETE ^H-NMR 
ASSIGNMENT IN A FAMILY OF SYNTHETIC LINKAGE ISOMERIC 
TRISACCHARIDES BY ONE-DIMENSIONAL NOE AND TWO-DIMENSIONAL 
NMR TECHNIQUES: CORRELATION WITH THE MOLECULAR MODEL
112
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INTRODUCTION
The importance of NMR for the structural elucidation 
of carbohydrates has grown vastly in the last decade. 
Most of the methods depend on the assignment of the 
signals. In many cases, the observation of the less 
crowded anomeric region suffices to monitor the success 
of synthetic reactions and for preliminary structures of 
biological oligosaccharides. Structural reporter groups 
in glycosides are well studied. Chemical shifts of many 
glycosides are well documented and reviewed (see for 
example references 123, 124). Although these references 
describe the high resolution 1H-NMR spectra of 
carbohydrate chains derived from N-glycosidic linked 
sugars of the N-acetyllactosamine and oligomannoside 
types, they are of immense importance in the present 
study. An attempt will be made to correlate some of the 
assignments of the synthetic saccharides described above 
with those reported in the reviews. Also, some of the 
interesting trends in the chemical shifts can be 
explained on the basis of the environment of the 
glycoside. This is made possible on the basis of the 
molecular model of the above glycosides which has been 
published recently.125
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NMR affords the only non-destructive method for 
analysis and obviates the need to work with derivatized 
samples, especially for linkage analysis. The latter if 
not impossible, is at least not routine in mass 
spectrometric methods. However, it needs to be mentioned 
here, the reports of the use of collision-activated 
dissociation, tandem mass spectrometry for the linkage 
position determination of the above glycosides without 
derivation.125' 126 Complete 1H-NMR assignment were 
done using homonuclear chemical shift correlation (COSY) 
experiments.127 For the linkage study, 1-dimensional 
n.O.e. experiments sufficed to provide the necessary 
information, using the ring proton assignments obtained 
by the COSY experiments.128
The following trisaccharides were analyzed:
F3 : L-FUCOSYLp (a 1-3 ) D-N-ACETYLGLUCOSAMINEp (131-3 ) D
-GALACTOSYLp(61-0-METHYL)
F4: L-FUCOSYLp(at 1-4)D-N-ACETYLGLUCOSAMINEp(61-3)D
-GALACTOSYLp(61-0-METHYL)
F6 : L-FUCOSYLp(al-6)D-N-ACETYLGLUCOSAMINEp(61-3)D
-GALACTOSYLp(61-0-METHYL)
Other NMR experiments used for linkage analysis are 
detailed in chapter four.
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MATERIALS AND METHODS
Chemical Shift Correlated experiments: Experiments
were performed on a Varian VXR-500 spectrometer equipped 
with a Sun 4/110 workstation at Glycomed Inc. About 6 mg 
of each of the trisaccharides were exchanged in D2O (99.9 
atom % D20 from Sigma Chemical Company) and lyophilized 
to remove the hydroxyl protons. This step was repeated 
three more times, the last lyophilization being carried 
out in the NMR tube itself. Finally, each of the samples 
were dissolved in 0.6 ml of high purity D20 (99.96 atom % 
D20 from MSD Isotopes). All experiments were performed 
at room temperature at 297 °K. Acetone at 2.225 ppm was 
used as an internal reference, indirectly referenced to 
2,2-dimethyl-2-silapentane-5-sulfonic acid (DSS). The 
homonuclear chemical shift correlated spectroscopy 
(COSY) is obtained using 2048 data points along the t2- 
axis for a spectral width of 2200 Hz.127 1024 data
points were acquired along the t 1-axis, which were zero- 
filled to 2048 points before Fourier transformation to 
give a digital resolution of about 2.2 Hz/point.
Nuclear Overhauser experiments: Experiments were
performed as described previously with a 3 second 
presaturation pulse and a 1 second delay between 
successive pulses.128
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RESULTS AND DISCUSSION
Figures 21a, 22a and 23a show the 1-dimensional
proton spectra while figures 2lb, 22b and 23b show the 2- 
dimensional magnitude COSY spectra of F3, F4 and F6 , 
respectively. These and other resonances are listed in 
table 4. No cross-peaks appeared for the galactosyl 
residue beyond the H-4 proton in any of the compounds. 
Hence, the remaining peaks in the proton spectra were 
assigned to the galactosyl H-5, H-6 and H-6 * protons.
This is done with the help of the observed n.O.e.'s (see 
below), the integration of the 1-dimensional proton 
spectrum and comparison of resonances of similar 
compounds reported elsewhere.
There were four peaks in the anomeric region of F3 
and F4, downfield of 4.2 ppm (figures 21a and 22a) . One 
of these, the quartet at 4.330 ppm for F3 and at 4.354 
ppm for F4, was due to the fucosyl H-5. The other three 
resonances were due to each anomeric proton of the 
residues of F3 and F4, confirming the presence of three 
glycosyl residues. The corresponding spectrum for F6 
(figure 23a) showed only three peaks downfield of 4.2 ppm 
(confirming the presence of three glycosyl residues) 
because the fucosyl H-5 proton of F6 was found about 0.25 
ppm more upfield in F6 than it was in F3 and F4. The 5 
ppm resonance of the a-Fucosy1 H-l was found
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progressively upfield in going from the 3 linked F3 to 
the 4 linked F4 and the 6 linked F6 , and was probably due 
to the increasing distance between the proton and the N- 
acetyl group. Interestingly, this trend was also 
reported in fucoses linked to N-acetylglucosamine 
residues from the N-linked octasaccharides.123' 124
However, comparison could only be made with the 3 and 6 
linked fucoses reported therein. Similar comparisons can 
be made with the H-5 and H-6 protons of fucose using both 
the values reported in the review and those observed for 
the above glycosides. The H-5 proton of the F6 fucose 
was the most upfield in both the cases. But the H-5
proton of F4 was found to be 0.02 5 ppm downfield with
respect to the H-5 proton from F3. H-6 protons of the
fucoses however, were found progressively downfield in 
the synthetic glycosides, with the H-6 proton of F6 
showing the most downfield shift of about 0.070 ppm, 
compared with those in F3 and F4. This can be explained 
on the basis of proximity of the fucose and galactose 
residue. This proximity was present in F4 and F6 , but 
not observed in F3 and is dicussed in detail below. The 
H-2 proton of F3 was found about 0.10 ppm upfield with 
respect to the same protons of F4 and F6 and the H-3 
proton of F6 was found about 0.06 ppm downfield with
respect to the same protons of F3 and F4. The H-3 proton
could be interacting with the galactose residue (see
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below). The H-2, H-3 and H-4 protons were not discussed 
in the reviews. Thus, even though the H-l, H-5 and H-6 
protons of fucose did not show the same chemical shifts 
as the N-linked glycosides reported in the reviews, they 
follow the same trend of field shift changes that reflect 
1inkage differences.
The N-acety1-glucosamine anomeric proton was 
downfield at around 4.7 ppm (J = 8.6 Hz), compared to 4.3 
ppm (J = 8.1 Hz) anomeric protons of the galactose
residue. The gradual progression observed in fucose was 
also present in the N-acetylglucosamine, but not 
galactose anomeric protons. As expected, significant 
differences were observed among the N-acetylglucosamine 
resonances of the three glycosides. These differences 
cannot be explained on the basis of linkages. The three 
dimensional energy minimized model of each was used for 
explaining these shifts. The energy minimized models of 
the three glycosides have been reported and are given 
here in figure 24.125
The chemical shifts of the H-3, H-4 and H-6 protons 
of N-acetyl glucosamine can be explained on the basis of 
the linkages. Thus, the most downfield H-3 proton was 
found in F3; the most downfield H-4 proton was found in 
F4 and the most downfield H-6 proton was found in F6 . 
Also, the most downfield H-5 proton was found in F6 and
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was probably due to the proximity of the H-5 and H-6 
protons and through-bond effects. The chemical shift 
differences among the H-2, H-6 ' and the N-acetyl methyl 
group protons however, cannot be explained on the basis 
of the linkage differences alone.
The H-2 protons in F3 of N-acetylglucosamine 
resonates about 0.11 ppm more downfield than in F4 and 
F6 . And the H-6 ' proton in F4 resonates about 0.10 ppm 
more downfield than in F3 and F6 . The former can be 
explained on the basis of the proximity of the N-acetyl 
group to parts of the fucosyl moiety, as shown in figure 
24a. This made the amino proton available for hydrogen 
bonding with the C-2 hydroxyl of fucose, which was on the 
same side of the plane formed roughly by the two glycosyl 
residues and is shown by the dashed line in the figure. 
For the same reason, the amino hydrogen was not available 
for reducing the carbonyl character of the N-acetyl group 
in F3. Hence, the methyl protons of the group appeared 
about 0.02 ppm more upfield in F3 than in F4 and F6 . 
This caused a corresponding and nearly equal but opposite 
effect on the fucosyl H-2, which in F3 was found to 
resonate about 0.10 ppm more upfield than in F4 and F6 . 
The N-acetyl and fucosyl C-2 hydroxy group proximity was 
not seen in F4 and F6 . Interestingly, the same fucose C- 
2 hydroxyl seemed to play a role in pulling downfield the
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H-6 ' of N-acetylglucosamine in F4 by 0.10 ppm, as stated 
above. It needs to be mentioned here, the report of the 
chemical shifts of H-6proS and H-6proR protons.129 The 
H-6proS proton chemical shift of D-mannose is reported to 
be more downfield than the H-6proR proton chemical 
shift. Assuming the same for the N-acetylglucosamine 
residue, the H-6 proton will be pros and the H-6 ' proton 
will be proR. The H-6 ' (or H-6proR) proton of F4 was in 
the proximity of the C-2 hydroxyl of fucose, and probably 
deshielded due to the oxygen as is seen in the dashed 
line of figure 24b. This would explain the large 
downfield shift of H-6 ' in F4 rather than in F6 , that one 
would expect on the basis of linkage arguments alone. It 
is quite probable that the effects of the proximity 
would overide the downfield shifts from the through bond 
effects from linkage characteristics. Lastly, this 
proximity was absent in the F3 and F6 compounds.
The differences in the chemical shifts of the protons 
of galactose among the glycosides were very minor. A 
noteworthy exception was the H-4 proton. It resonated 
around 4.13 ppm in F6 and around 4.10 ppm in F3 and F4. 
Because the linkage isomerism was in the non-reducing end 
of the disaccharide unit, the galactose residue was 
ignored in the molecular model. This will make 
comparisons among F3, F4 and F6 involving the galactosyl
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residue difficult, if not impossible. One can, however, 
presume that the glycosides will have the same general 
orientation as when a hydrogen replaces the galactose, as 
in the model. With this assumption, one does see 
different orientations between the residues causing 
different moieties in fucose to interact with parts of 
galactose. The H-3, H-5 and H-6 fucose protons were seen 
to jut out towards the reducing end hydrogen, more 
prominently in F6 than in F3 and F4, which may explain 
the downfield trend among these protons in the 
glycosides. It is likely that the galactosyl H-4 proton 
is involved in this interaction. The observed trend was 
not followed, in the case of the fucosyl H-5 proton in 
F4. It is very likely that it is placed in a better 
position in F4 than in F3 or F6 for the above 
interactions, causing the downfield shift. The n.O.e. 
data corroborate the fucosyl and galactosyl interactions, 
since a pre-irradiation of galactose H-l or H-4 protons, 
or fucosyl H-l protons show the appropriate n.O.e.'s and 
is discussed in detail below.
Significant results were obtained using l-dimensional 
n.O.e. experiments. The n.O.e. data are given in Table 
5. Figure 21c shows two n.O.e.'s with the pre­
irradiation of the H-l proton of the fucosyl residue of 
F3. The n.O.e. at 3.70 ppm was an intraresidue n.O.e.
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from the H-2 proton of the fucosyl residue and the other 
at 3.67 ppm was from an interresidue n.O.e. from the H-3 
proton of N-acetylglucosamine. The latter n.O.e. 
strongly pointed towards a 1-3 linkage between the two 
residues. No n.O.e. was observed from any galactosyl 
protons, indicating no detectable interactions between 
the two, as predicted above. Pre-irradiation of the H-l 
proton, of N-acetylglucosamine, in figure 2Id showed five 
n.O.e.'s. Three of these were intraresidue n.O.e.'s. 
Two of the n.O.e.'s at 4.14 and 3.71 ppm were due to 
interresidue n.O.e. from the H-4 and H-3 protons of the 
galactosyl residue. The later n.O.e. was much stronger 
than the former, indicating a more likely 1-3 rather than 
a 1-4 linkage.
Pre-irradiation of the H-4 proton of the galactose 
residue showed 8 n.O.e.'s, as shown in figure 21e, three 
of which were interresidue. The negative interresidue 
n.O.e.'s at 3.91 and 3.88 ppm were due to the H-6 and H-2 
protons of N-acetylglucosamine, respectively. The 
fucosyl H-5 proton was pre-irradiated along with the 
adjacent galactosyl H-4 proton, and most likely was not 
an n.O.e. One of the intraresidue n.O.e.'s at about 3.68 
ppm was assigned to the H-5 galactosyl proton, not 
obtained from the COSY.
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Similar studies with F4 showed five interresidue 
n.O.e.'s on pre-irradiation of fucosyl H-l (see figure 
22c). Three of these were due to the H-4, H-6 and H-6 ' 
protons of N-acetylglucosamine, at 3.58, 3.95 and 3.87 
ppm, respectively. The magnitude of the H-4 proton n.O.e. 
being the largest among these, the most likely linkage 
here was 1-4. Minor galactosyl interresidue n.O.e.'s 
observed at 4.14 and 3.54 ppm were due to the H-4 and H-2 
protons, respectively. This latter evidence corroborates 
the statement made above of the likelihood of the 
proximity of parts of the galactosyl and fucosyl 
residues. This proximity was more prominent in F6 {see 
below) than in F4, and in turn, more in F4 than in F3. 
Pre-irradiation of the H-l proton of N-acetylglucosamine, 
in figure 22d showed galactosyl H-2, H-3 and H-4 protons 
at 3.54, 3.71 and 4.14 ppm, respectively. From the
magnitude of the n.O.e.'s, the linkage was most likely l- 
3. However, the 1-2 and 1-4 linkage cannot be entirely 
ruled out. But, the pre-irradiation of the galactosyl H- 
4 proton ruled out the later (see below). Pre­
irradiation of the galactosyl H-4 proton, shown in figure 
22e gave interresidue fucosyl H-3 proton and H-5 protons 
(though the latter could be a pre-irradiation rather than 
an n.O.e.) and the interresidue N-acetylglucosamine 
protons H-2, H-6 and H-6 ' at 3.8 8 , 3.91 and 3.76,
respectively. This indicated a more likely 1-3 linkage
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between N-acetylglucosamine and galactose, since a strong 
n.O.e. of the H-l proton of the former was not observed. 
Figure 22f shows the pre-irradiation of the H-5 and H-l 
protons of the fucosyl and galactosyl protons, 
respectively. This showed only the intraresidue n.O.e's. 
The likelihood of at least some of these being 
interresidue n.O.e.'s cannot be ruled out, since pre­
irradiation of fucosyl H-l could show galactosyl n.O.e.'s 
if the molecule is "C-shaped".
Finally, the pre-irradiation of the H-l proton of 
the fucosyl H-l from F6 showed a strong interresidue 
n.O.e. at 3.98 and 3.78 ppm, respectively, confirming the
1-6 non-reducing end linkage as seen in figure 23c. Pre­
irradiation at the H-l proton of the N-acetylglucosamine 
residue, in figure 23d shoved a strong interresidue 
n.O.e. at 3.70 ppm for the H-3 proton of galactose 
indicating a 1-3 "reducing end" linkage. Lastly, pre­
irradiation of the H-l proton of galactose in figure 23e 
showed interresidue n.O.e. for the H-3 and H-5 protons of 
fucose, and H-6 proton of N-acetylglucosamine. The 
observation of the fucosyl protons further corroborates 
the chemical shift data which was explained above on the 
basis of the proximity of fucose and galactose. In F6 , 
this proximity seems equidistant from the H-3, H-5 and H- 
6 protons of fucose, explaining the chemical shift change
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in going from F3 to F4 to F6 . In F4, this proximity is 
most likely between part of galactose and the fucosyl H-5 
proton only. This should explain the chemical shift 
trend, and the downfield shift of the H-5 proton of 
fucosyl F4.
In conclusion, application of homonuclear 2- 
dimensional chemical shift correlated spectroscopy 
and 1-dimensional n.O.e., for the linkage determination 
of glycosides is very useful. This, despite the fact 
that there is a severe spectral overlap for sugars in 
the proton spectrum for the former and the strong 
dependence on conformation for the latter. Though the
COSY spectrum did not give all the expected cross-peaks,
the absence of three resonance assignments per compound 
was a major problem. In any case, these were assigned on 
the basis of the integrated regions of the proton 
spectrum and in some cases, the observed n.O.e. Thus, 
this indicates the benefits of using these two 
complementary methods for the structural determination of 
intact, non-derivatized glycosides. This becomes 
extremely important when there is limited amount of
sample and methods such as selective INEPT130 cannot 
be used due to the low abundance of 13C and
precludes the use of the time consuming HETCOR (H-C 
correlation) experiments.
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Finally, chemical shifts due to glycosidation caused 
a range of 0.002 to 0.07 ppm differences in the linkage 
carbon's protons. However, conformational considerations 
caused significant (upto 0.11 ppm) shifts in other 
protons due to linkage changes, which required recourse 
to using three dimensional structural models. This is 
not to say that the three dimensional model is not a 
consequence of the two dimensional structure, but that, 
some of the observed changes are not immediately obvious 
from the glycoside sequence alone. Such multiple ring 
proton shifts are more significant than the glycosidation 
shifts because they point to the fact that the shifts can 
be used an important identity for these glycosides. 
These observations make closely related compounds 
amenable for detection using computerized approaches to 
the structural analysis of carbohydrates. Such 
approaches are more important for carbohydrates than for 
other biomolecules of same size because of the structural 
diversity observed in the former. This points to the 
importance of establishing a database for comparisons 
with glycosides already analyzed. Jansson et al.131 have 
reported a range of chemical shift changes due to 
glycosidation. Thus, a beginning has been made in this 
direction with the introduction of the computer program 
CASPER, which has been previously used for poly­
saccharides and is now being used for the structural
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elucidation of smaller glycosides. The chemical shift 
differences noted above for the linkage isomeric 
glycosides are definitely suited for their elucidation by 
such a program, where differences of 10 % would suffice 
to differentiate between structures. Needless to say, 
the need for the routine use of such a program would save 
a lot of valuable time and effort, and its importance 
cannot be overstated.
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Table 4. ■^H chemical shift and coupling constant4 data 
for L-Fucosyl_- (atl-X) -D-N-acetyl-D-glucosminylp— (61-3) -D- 
galactosylp-(Bl-O-methyl) where X - 3,4, or 6.
Res f -
dus
Rep­
orter
group
X - 3 X a 4 X a 6
Fuc K-1 5.000 (4.0) 4.957 (3.8) 4.920 (3.9)
H-2 3.698 <4.0, 8.2) 3.792 (3.2, 10.9) 3.790 (3.9, 9.7)
H-3 3.835 <10.4, 3.4) 3.834 (10.7,3.2) 3.898 (10.4, 3.4)
H-4 3.797 <3.0, 0.8) 3.802 (3.8, 0.0) 3.806 <2.7)
H-5 4.330 <0.0, 7.0) 4.354 (0.0, 6.6) 4.085 (0.0, 7.4)
H-6 1.159 <6.7) 1.161 (6.7) 1.231 (6.6)
Ctc* Ac H-l 4.711 (8.6) 4.702 (8.5) 4.701 (8.5)
H-2 3.876 <9.0, 10.1) 3.768 <7.8, 7.8) 3.769 (8.3, 8.3)
H-3 3.671 (9.9, 9.9) 3.669 (8.3, 8.3) 3.574 (7.4, 7.4)
H-4 3.345 (9.1, 9.1) 3.378 (9.7, 9.7) 3.573 (7.4. 7.4)
H-5 3.463 <10.0, 5.3, 2.3) 3.321 <9.3, 4.4, 2.1) 3.670 (4.2, 7.8, 0.4)
H-6 3.909 (5.3, 12.3) 3.952 (2.0, 12.2) 3.983 (0.5, 11.4)
H-6' 3.765 <2.0, 12.2) 3.865 (4.2, 12.4) 3.783 (4.0, 10.4)
KHCOCH^ 2.015 2.035 2.035
Gel H-1 4.300 (8.0) 4.303 (8.0) 4.299 (8.1)
H-2 3.341 <7.9. 7.9) 3.349 (7.9, 7.1) 3-556 (7.9, 10.6)
H-3 3.707 <7.0, 3.1) 3.711 (6.6, 3.5) 3.708 <10.2, 3.1)
H-4 4.138 <2.7, 0.3) 4.140 (3.2, 0.0) 4.103 (3.4, 0.0)
H-5 3.685 <0.0, 7.9, 4.8) 3.682 (0.0, 8.5, 4.8) 3.670 (1.0, 7.9, 4.3)
H-6 3.763 <7.6, 11.8) 3.772 (7.0, 13.5) 3.772 <8.0, 13.4)
H-6' 3.736 (7.9, 11.9) 3.7135 (5.0, 12.8) 3.731 (5.6, 13.4)
o c h3 3.564 3.564 3.564
aIn crowded ring proton regions, average J values are 
used; when J1 and J2 values are very different, the more 
realistic one is listed above. Some J values are assumed 
from related resonances.
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Table 5. N.O.e. data obtained by pre-irradiation of four 
downfield resonances of F3, F4 , and F6 . A, B and C stand 
for the fucose, N-acetylglucosamine and galactose 
residues respectively, of the appropriate glycoside.
Glycoside Irradiation of
A H-l B H-l C H-l A H-5
C H-l
Observed n.O.e.'s
C H-4
F3 A H-2 B
CN1X A H-5
B H-3 B H-4 B H-2
B H-5 B H-6
C H-3 c H-l
c H-4 c H-2
c H-3
c H-4
c H-5
F4 A H-2 B H-2 A H-3 A H-4
A H-3 B H-3 A H-4 A H-5
A H-4 B H-4 C H-2 B H-2
B H-4 B H-5 C H-3 B H-6
B H-6 C H-2 C H-4 B H-6 '
B H-6' C H-3 C H-5 C H-l
C H-2 C H-4 -o c h 3 C H-3
C H-4 c H-5
F6 B H-6 B H-4 A H-3
B H-6' C H-3 A H-5
B H-6
C H-2
C H-3
C 1
X
c X 1 ui
-OCH3
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Figure 21. Structures of (a)RKJ3 (b)RKJ4 and (c)RKJ5. 
Some protons are not shown.
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Figure 22. 500 MHz (a) l-dimensional and (b) ^H-
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Figure 23. N. O. e. difference spectroscopy experiments
with pre-irradiation of (a) AH1 (b) BH1 and (c) CH4
protons of F3.
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Figure 24. 500 MHz (a) 1-dimensional LH and (b
COSY 90 spectra of F4.
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Figure 25. N. O. e. difference spectroscopy experiments
with pre-irradiation of (a) AH1 (b) BH1 (c) CH4 and
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Figure 26. 500 MHz (a) 1-dimensional 1H and (b)
COSY 90 spectra of F6.
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Figure 27. N. O. e. difference spectroscopy experiments
with pre-irradiation of (a) AH1 (b) BH1 (c) CH1 protons
137
( b )
a-L*Fuco3yl(1->4)P-C-GlcNAc
(a)
a-L-Fucosyl(1 ->6)jJ-Q-GIcNAc
a-U-Fucosyl(1-»3)[i-£-GlcNAc
Figure 28. Energy minimized molecular models of (a) F3
(b) F4 and (c) F6 .
CHAPTER 4 . HIGH RESOLUTION NMR STUDIES OP ERYTHRO 
GLYCAN AND SYNTHETIC ERYTHROGLYCAN-LIKE SACCHARIDES
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INTRODUCTION
This chapter describes various characterization 
methods of a series of oligosaccharides using high 
resolution NMR experiments. The basic strategy chosen 
for the characterization of most of the compounds was 
described in detail in chapter 3. This included a two- 
dimensional COSY experiment for the assignment of most if 
not all the protons. With this identity of the compound 
established, a one dimensional nuclear Overhauser 
experiment gave detailed information about the linkages 
between the various residues. The anomeric configuration 
of each residue was directly obtained from the one 
dimensional proton spectra of the compound. The
chemical shift values of the anomeric protons of 
different residues in various environments is well 
documented and extensive use was made of such 
information.123' 124 Other methods of characterizations 
are also available for linkage analysis and form the 
substance of the initial portion of this study. 
Glycosides already characterized are sometimes chosen for 
comparison of methods.
The number of possible structures from a given fixed 
number of residues is much larger for a carbohydrate 
structure than for a nucleic acid or protein molecule. 
This complexity is due to the various permutations of
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positions sugar sequence, linkage and anomeric 
configuration. For a sugar structure containing N 
different hexoses, the number of possible structures is 
given by the formula:
S* = N! x 2Na x (4)N_1 x 2Nr
where N! is sugar epimer order, 2^a is anomeric 
configuration, position of linkage is (4)N “ 1 and ring 
size is 2Nr .125 This formula is for a linear string of 
hexoses and does not take into account the possibility of 
branching. For a saccharide composed of 5 hexoses, the 
above formula predicts a staggering 31,457,280 possible 
structures. Taking into account the possibilities of 
branching, anomers, and different enantiomers, the number 
increases to about 2 billion. The largest contribution 
to these numbers are from the linkage term, (4)N_1, and 
most carbohydrate instrumental methods focus on linkage 
analysis.
The following compounds* were synthesized by Dr. 
Rakesh K. Jain (RKJ) in the laboratory of Dr. Khushi L. 
Matta of the Roswell Park Memorial Hospital, Buffalo, New 
York:
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Compound Rea idue (linkagej
A B C
RKJ1 D-Galp(fll-4) D-GlcNAcp(fll— 3) D - C a l p (fll-O-Me)
10012 D-Galp(fll-fi) D-GlcNAcp (J31-3) D-Galp(fll-O-Me)
RKJT2 D-Galp(fll-3) D-GleNAcp{fll-3) D- G a l p (fll-O-Me)
RKJ3 1-Fucp (Q£ 1— 3 ) D-GleNAep(01— 3) D-Galp(fll-O-Me)
RRT4 L-Fucp (a 1-4) D —GlcNAcp (fll-3 ) D-Galp(fll-O-Me)
RKJ5 L-Fucp (a 1-6) D-GlcNAcp(fll— 3) D-Galp(fll-O-Me)
RXJ9 3-0-Me-D- 
GlcNAcp (fll— 3 )
D-Galp (fll—O - M e )
RXJ10 4-O-Me-D-
GlcNAc(fll— 3 )
D-Galp(fll-O-Me)
RKJ11 2-O-Me-D- 
GaIp(fll-3)
D-GlC.NAcp (fll-0-3n)
*The following abbreviations are used for the structures:
Gal: Galactose Ac: Acetyl
GlcNAc: N-acetylglucosamine Me: Methyl
Fuc: Fucose Bn: Benzyl
p: Pyranose
All the compounds listed above possess the same 
residues that are found on erythroglycan, as will be 
discussed below. The only difference, besides the size, 
or presence of small groups on some glycosides is the 
sequence, or linkage differences in some members of 
linkage isomeric family of saccharides. Since the
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intention of this study was to arrive at an idea of 
limits of resolution to distinguish such isomers, the 
synthetic sugars were invaluable for this part of the 
study. RKJ1 among all the glycosides listed above, is 
identical to a building block of erythroglycan. Other 
residues, such as fucose and N-acetylgalactosamine 
(GalNAc) form part of erythroglycan of certain blood 
groups. As such, all these glycosides will be referred 
to as erythroglycan-like (EG-like) saccharides.
The basic purpose of the experiments described in 
this chapter was to use the least number of NMR 
experiments, with minimal if any, wet chemistry to 
confirm the structure of the synthesized product. In the 
absence of such information, the use of GO analyses would 
be suggested.
All the NMR experiments focus on the need to derive 
linkage information. Most of these were successful, but 
some had advantages over others with respect to the ease 
of the experiment, sensitivity, resolution, time of 
experimentation and information content.
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MATERIAL AND METHODS
Several different NMR experiments were performed to
characterize the compounds listed above. These were:
correlation spectroscopy (COSY) , 127 long range COSY
(COSYLR) , 332 multiple step relayed correlation
spectroscopy (relayed COSY)133, two dimensional nuclear
Overhauser effect spectroscopy (NOESY) ,134 one
dimensional n.O.e ., 128 heteronuclear correlation
spectroscopy (HETCOR) , 135 homonuclear Hartmann-Hahn 
1 "1 6(HOHAHA) and selective nuclear polarization transfer
(INAPT).13° of these, the COSY and one-dimensional 
experiments were described in detail in chapter four. 
The rest of the experiments are described below.
All proton spectra run in D20 solvent used internal 
acetone a„s reference (2 . 225 ppm) , indirectly referenced 
relative to 2 , 2-dimethyl-2-silapentane-5-sulfonic acid 
(DSS). Spectra run in mixed or DMS0-d6 solvents were 
referenced relative to the DMSO solvent (2.49 ppm for 
proton spectra and 39.5 ppm for carbon spectra).
Long Range COSY:
One of the first experiments that was used for 
deriving linkage information was long range COSY. Also 
called delayed COSY, the experiment was run as described 
by Batta et al.132 The long range COSY depends on the
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■^ H and "^ H spin-spin coupling through the interglycosidic 
oxygen or 4jhC0CH coupling constant. This coupling 
constant was not measured but assumed to be lower than 
0.2 Hz, as reported in the above reference for typical 
oligosaccharides. Hence, the same parameters as reported 
by the authors were used to characterize the glycosides 
and is described for one of the oligosaccharides (RKJ5) 
listed above.
5 mg of RKJ5 was dissolved in 0.5 ml of D20 (99.96
atom % from MSD Isotopes) after repeated exchanges with
D20 (99.9 atom % from Sigma Chemical Company), to make a
final concentration of about 20 mM. Two-dimensional
delayed COSY experiment was run at room temparature (298
K) with 512 X 1024 data points, each incremented by l ms.
A 2 second recycle delay was incorporated between each 
0
pulse and an extra delay of 0.4 s was inserted before the 
evolution and the 0.512 s detection period. Quadrature 
detection was applied in both directions using a 16 step 
phase cycling, data multiplied with a sine-bell shaping 
function, zero filled to IK X 2K, Fourier transformed and 
symmetrized. Suitable contour maps were plotted to 
assign the linkages.
Relayed COSY: Relayed COSY was performed according
1 T
to Homans et al. In brief, incremental delay, t-^  of
50 ms and a second delay, t2 , of 50 ms was applied. The
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delay t3 was kept constant at 20 ms. The tj and t2 
values are dependent on coupling constants of adjacent 
protons, which range from about 2 Hz to about 14 Hz. An 
average value of 8 Hz is assumed and the delays 
approximated to 1/2J or 5 0 ms. For t3 , an average of the 
range used by authors was used. The experimental 
conditions and data processing were identical to those 
described for the COSY experiments.
HETCOR
1 1 1H- C correlation experiment was performed according 
to Bax.*35 This involved using fixed delays of 1.5 sec 
(approximating the sample proton relaxation time), 4 msec 
and 2 msec, respectively for the pulse sequence, a 9 0° 
proton pulse of 9.5 usee, a 90° carbon pulse of 6 usee 
and an incremental delay of 3 usee.135 The processing 
was similar to the COSY experiments, except that a 
Gaussian shaping function was applied in the F2 dimension 
with a line broadening of 2 Hz.
HOHAHA:
2-dimensional HOHAHA experiments were performed 
according to Bax et al.136 MLEV-17 mixing was used 
according to the pulse sequence: 9O°0-SLX-(MLEV-17)n-SLx~ 
Acq, where SLX is the spin lock along the x axis and n is 
the number of times the MLEV-17 sequence is cycled. Two 
sets of IK X 256 data points were acquired and the data
146
processed according to States et a l .137 Gaussian 
transform was applied with a line broadening of 2 Hz in 
both dimensions and the dimension zero-filled to 512 
points. A digital resolution of about 3 Hz was obtained. 
In the low power transmitter mode 2 watts of 
radiofrequency power was used (90° pulse of 30 us).
Two-dimensional NOESY experiments:
The two-dimensional NOESY experiment was performed at 
room temperature (298 K) with a 250 ms mixing time.134 
The 2D time domain spectra was zero filled, multiplied by 
a Lorentzian-Gaussian function and transformed to give 
2.2 Hz/point and 4.0 Hz/point resolution respectively in 
the t2 and tl domains. NOESY experiments were performed, 
among others, on erythroglycan of figure 2. The fraction 
with approximate molecular weight 7 kDa, was chosen and 
run on a reverse phase HPLC according to Levery et al.138 
The largest peak eluting out and showing positive 
reaction with orcinol H2S0 4 test was treated as described 
above for NMR sample preparation.
Selective INEPT (insensitive nuclei by enhancement of 
polarization transfer):
The selective INAPT or INEPT experiment was run 
according to Bax et al.130 All processing and other 
conditions were according to the reference, which
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described INAPT 
Assuming similar 
sugars, the two 
reference.
experiments using 
four bond coupling 
delays were set at
sugar solutions, 
constants in RKJ 
50 ms as per the
The figures and tables are given after the results 
and discussion below.
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RESULTS AND DISCUSSION
For the purpose of brevity, all residues listed in 
the RKJ samples are labelled A, B, C. . . . etc., from the 
non-reducing end to the "reducing end". For example, for 
RKJ3, the fucose (Fuc) would be residue A, the N-acetyl- 
glucosamine (GlcNAc) would be residue B and galactose 
(Gal) would be residue C.
RKJ3, RKJ4, and RKJ5:
These were discussed in detail in chapter three 
above, where RKJ3, RKJ4, and RKJ5 were named as F3, F4, 
and F6 , respectively.
RKJ9, RKJ10 and RKJ11:
Table 6 lists the proton chemical shifts of RKJ9 and 
RKJ10 in D20. The shifts were assigned by using results 
from both the relayed (figure not shown) and normal COSY. 
Figures 30a and 35a show the one-dunensional H-spectra 
of RKJ9 and RKJ10, respectively. Figures 30b and 35b 
show the two-dimensional COSY 90 1H-^H spectra of RKJ9 
and RKJ10, respectively. The use of COSY for assignment 
of protons distant from the anomeric region, especially 
galactosyl H-5 and H6 protons, was inadequate. Use was 
made of the fact that protons neighbouring the anomeric 
region show up in a line in the less crowded H-i space of 
the two-dimensional spectrum. Because the sequence of
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the protons cannot be discerned from the linear array,
results from a normal COSY have to be used too.
The selective INEPT experiment was used for linkage 
determination. The linkages thus obtained were confirmed 
using 1-dimensional n. 0. e. experiment. Prior to the 
INAPT experiment, a ^H-13C heteronuclear experiment was 
run to assign the RKJ9 carbons using the proton
assignments. However, the solubility of RKJ9 in D20 was
the limiting factor and the inherent insensitivity of 
detecting carbons in comparison to protons prompted 
running RKJ9 in DMSO-d6 instead. The solubility of RKJ9 
in DMSO was fortunately high but the proton spectrum 
showed a large HOD peak, probably from the hygroscopic 
nature of DMSO, which obscured the ring proton region 
(figure not shown). Finally, 33 % 02O solution was made, 
which moved the HOD peak into the less crowded anomeric 
region.
Table 7 lists the proton chemical shifts of RKJ9 and 
RKJ10 in 33 % D20 in DMSO-dg. The assignments were made 
from the corresponding COSY spectra, which are shown in 
figures 31b and 36b, whereas the 1-dimensional spectra in 
the mixed solvent are shown in figures 31a and 36a, 
for RKJ9 and RKJ10, respectively. The carbon spectrum of 
RKJ9 and the HETCOR correlation are shown in figures 32a 
and 32b, respectively. Table 8 lists the carbon chemical
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shifts of RKJ9 only. The amount of RKJ10 was
not sufficient for running a HETCOR experiment, where all 
the cross-peaks showed. Figure 3 3 is the INAPT spectra of 
RKJ9, where the transfer from proton H-l of residue A 
showed three carbons. Two of these carbons were 
recognized from the HETCOR assignment as intraresidual C- 
3 and C—5 carbons of residue A. The third, upfield
carbon was the interresidual c-3 from residue B,
indicating a 1-3 linkage between the two residues, where 
residue A is non-reducing. The experiment was run, but 
had an inadequate signal to noise ratio.
The linkage assignment was confirmed from the 1-
dimensional n. O. e. experiment (fig. 34a and 34b). 
Pre-irradiation of H-l of residue A showed four prominent 
n. O. e.'s. A strong n. 0. e. around 3.40 ppm was due to 
interresidual H-3 proton of B. This confirmed the 1-3 
linkage assignment between A and B, as was determined 
using the INAPT experiment. Going upfield, other
n. O. e.'s were intraresidual H-2, H-3, and H-5 protons 
of A, as labelled in the figure. Pre-irradiation of the 
upfield 0 -methyl proton, showed a strong intraresidual 
n. 0. e. of the H-l proton of B (figure 34b). The 
absence of an n. 0. e. of the H-3 proton of A confirmed
the upfield 0-methyl proton as belonging to the B residue
and the downfield to the A. The last n. O. e. was done
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for the RKJ9 sample dissolved in D20. The chemical 
shifts in the two solvents though slightly different, 
were assumed to be unaffected to the point that the 
methyl groups may not interchange in either solvents.
RKJ9 and RKJ10 can be considered members of the same 
EG-like family, differing only the position of the methyl 
group on residue B. Due to the limited amount of RKJ10, 
the n. 0. e. experiment was run in place of the INAPT 
experiment. Though considered to enhance a -^c signal by 
a factor of four, the need to run a HETCOR is an 
unattractive feature of an INAPT or INEPT experiment, 
especially in cases of sample amount limitations. 
Despite the conformational effects that complicate or 
confuse n. O. e. results, the experiments most of the 
times afford the right 1inkage information. Also, 
standard n. O. e. relaxation and saturation times can be 
used for most saccharides without having to derive any 
parameters. INAPT experiments, on the other hand, are 
very sensitive to delay values. The most critical factor 
in applying the INAPT experiment for linkage 
determination is the size of the three bond 3Jhcoc value- 
This four bond coupling constant depends on the dihedral 
angle, in a Karplus-type relationship and is different 
even for similar looking compounds. In the absence of 
knowledge of this value, the success of the experiment
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using average values from similar compounds is a matter 
of sheer luck.
All n. 0. e. experiments of RKJ10 were performed in 
the mixed solvent system. Pre-irradiation of the H-4
proton of residue A showed the downfield O-methyl 
n. 0 . e., indicating the position of methylation on the
residue (fig. 37a). Hence, as in the case of RKJ9, the
upfield O-methyl resonance belongs to the anomeric 
hydroxyl of the "reducing" group residue. Figure 37b
shows the pre-irradiation of the H-l proton of A, which 
gave rise to mainly two n. O. e.'s. The n. O. e. at 
about 3.40 ppm was the H-3 of B, indicating a 1-3 
linkage, and the n. O. e. at about 3.47 ppm was the
intraresidual H-2 proton of A. Pre-irradiation of the H- 
1 proton of B showed intraresidual n. O. e.'s of the 0- 
methyl and H-2 protons of B, as shown in figure 37c, 
confirming it's "reducing" end position and the presence 
of the anomeric O-methylation. Figure 38 shows the 
carbon spectrum of RKJ10 and in the absence of a HETCOR 
experiment, the peaks were not assigned.
RKJ11 can be said to belong to the RKJ9 and RKJ10 
group. However, there are many differences between the 
latter two and RKJ11. Not only is the reducing end in 
RKJ11 blocked by a different group (benzyl), but the 
sequence in which the residues appear is reversed. In
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the absence of these differences, RKJ11 would have been a 
more valuable compound for NMR study and comparison with 
RKJ9 and RKJ10. The proton spectrum of RKJ11 is shown in 
figure 40a and the chemical shift assignments are given 
in table 9. The latter are obtained from the COSY 
spectrum, shown in figure 40b. N. O. e. experiments of 
RKJll for linkage assignments are shown in figures 41a to 
41c. Pre-irradiation of the O-methyl group shows 
intraresidual n. 0. e. of the H-2 proton of A, indicating 
a methylation at that position (fig. 41a). Also, the 
interresidual n. O. e. of the H-4 proton of B was 
observed. Pre-irradiation of the H-l proton of A shows 
intraresidual H-2 and H-4 protons of A and interresidual 
H-3 and H-6 protons of B, indicating a likely 1-3 or 1-6 
linkage (fig. 41b). However, the linkage between A and 
B was assigned as 1-3 because, pre-irradiation of the 
methyl group of A showed the H-3 and not the H-6 proton 
of B (see above). This can only occur if the H-l proton 
of A and the H-3 proton of B are in proximity, which in 
turn can only happen if they are 1-3 linked. Pre­
irradiation of the H-l proton of B shows a weak benzyl 
n. O. e., indicating it's "reducing" end position (figure 
41c). Also observed were intraresidual H-3, H-6 and H-2 
protons of residue B. The pre-irradiation of H-l of each 
residue affected the neighbouring H-l proton to some 
extent, but the results were unambiguous, probably
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because the effect of the pre-irradiated peak was much 
larger than from the "spillover" irradiation. RKJ9 and 
RKJ10 n. 0. e. results are summarized in table 10 and 
RKJll n. O. e. results are given in table 11.
RKJ1, RKJ2 and RKJ12:
RKJ2 decomposed to an unknown structure during 
handling and the proton spectra did not show any anomeric 
protons (f igure not shown) . RKJ1 and RKJ12 proton
spectra are shown in figures 43a and 45a, and the COSY
spectra are shown in figures 43b and 45b, respectively.
The chemical shift assignments obtained from the normal 
COSY and relayed COSY (figure not shown) are summarized 
in table 1 2.
Figure 44a shows the pre-irradiation of the 0-methyl 
proton of RKJl, which gave the H-l proton n. O. e. of
residue C, indicating the "reducing" position of the
residue. Figure 44b shows the pre-irradiation of the H-l 
proton of residue B, which gave the intraresidual 
n. O. e.'s at protons H-2 and H-6 . Also observed was the 
interresidual n. 0. e. at proton H-3 of C, indicating a 
1-3 linkage between B and C residues. Figure 44c shows 
the pre-irradiation of the H-l proton of A. Intra­
residual n. O. e.'s of the H-2 and H-3 protons of A were
observed. Interresidual n. O. e.'s at about 3.74 ppm and
3.97 ppm was due to the H-4 and H-6 protons of B,
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indicating a 1-4 or 1-6 linkage respectively, between 
the A and B residues. The former n. O. e. being much
stronger than the latter, by about a factor of two, the
linkage was assigned as 1-4. Surprisingly, the H-4 
proton of C was also observed and this was most likely 
due to a conformation of RKJ1, whereby the molecule 
assumes a C-shape, providing proximity to H-l proton of A 
and H-4 proton of C.
Figure 46a shows the pre-irradiation of the O-methyl 
protons of RKJ12, giving an n. O. e. at the H-l protons 
of C, confirming the "reducing" end position of C. Pre­
irradiation of the H-l proton of A shows the
intraresidual n. 0. e. at the H-2 proton of A, and
interresidual n. O. e. at the H-3 and H-6 protons of B, 
indicating a likely 1-3 or 1-6 linkage (fig. 46b). The 
intensities of both the interresidual n. O. e.'s were 
same, making it difficult to predict the linkage. 
However, pre-irradiation of the N-acetyl proton of
residue B showed an n. O. e. effect on the H-l proton of
A (figure not shown), indicating that the linkage between 
A and B was most likely 1-3. In case of a 1-6 linkage, 
the N-acetyl protons would be too far removed from the H- 
1 proton of A, giving no possibility of an n. 0. e. 
effect. Finally, the pre-irradiation of the H-l proton
of B showed intraresidual n. O. e. at H-2 and H-6 protons
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of B, and interresidual n. 0. e. at proton H-3 of C, 
indicating a 1-3 linkage at the "reducing" end (figure 
46c). Table 13 summarizes the n. 0. e. results of RKJ1 
and RKJ12.
Long range COSY:
Traditionally, sequencing of organic oligmers has 
been done using n .O.e. experiments (one- or two- 
dimensional) . Typically, small proteins have been 
sequenced in the laboratory of Wiithrich using this 
methodology,139, 140» 141 oligopeptides by Hull142 and
oligosaccharides by Prestegard and Koerner.143 The latter 
method was mostly used for the characterization of RKJ 
samples and EG. Two-dimensional NOESY experiments permit 
sequence information through correlations obtained from 
dipolar relaxation or cross relaxations between protons 
in adjacent residues. Such information can also be 
obtained from indirect homo- or heteronuclear long range 
coupling. Two such experiments used in characterizing 
oligosaccharides are extensively used. One of them, the 
selective INAPT was described above. This section 
describes in brief, the linkage information obtained with 
using long range 1H-1H spin-spin coupling through 
interglycosidic oxygen.132 It differs from the INAPT 
experiment in being a homonuclear experiment that 
precludes the need to run insensitive 2-dimensional
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correlated carbon spectra. However, it is similar to the 
INAPT experiment in being extremely parameter sensitive, 
and the success of the experiment depends on the
knowledge of the four bond 4Jhcoch couPlin(3 constant.
Application of long range COSY to the RKJ5 sample 
showed transfer from the H-l proton of residue A to the 
H—6 proton of residue B, indicating a 1-6 linkage 
{fig. 4 7). Transfer of H-l proton of residure B showed 
cross-peak at the H-3 proton of residue C, indicating 1-3 
linkage. The results confirm assignments made with the 
1-dimensional n. 0. e.'s, described in Chapter 3.
Homonuclear Hartmann-Hahn (HOHAHA):
Application of HOHAHA to several of the compounds 
gave results similar to the relayed COSY (data not 
shown). Observation of 3-4 protons in a single array 
near the anomeric region of the 2-dimensional spectra, 
allowed easy access to the ring proton region for
assignments. However, since the sequence in which the 
protons in the array appear is not normally known, a
prior running of COSY was required. In most cases the
latter afforded the complete assignment, especially in 
conjunction with an n. 0 . e. or other experiment and the 
need to run HOHAHA was not felt to be as crucial. 
However, in cases of higher order sugar, containing more
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than five different residues, the HOHAHA experiment would 
be the method of choice.
Erythroglycan (EG):
The GC results of the 7 kDa EG fraction are shown in 
table 14. Erythroglycan was reported to be a poly- 
lactosaminy1 biantennary bisected structure possessing 
the core mannose moiety present in all N-linked 
sugars.144' 145 The three mannoses present in the 
GC analysis are part of the mannose core. 60 % of EG 
structures were reported to be bisected by N- 
acetylglucosamine (GlcNAc). Since the ratio of the 
GlcNAc to Galactose (Gal) accounts for most of the 
GlcNAc, the GlcNAc amount fell short by one, for the 
presence of this residue in the bisected portion. This 
either indicates the inability to detect the sugar in the 
GC analysis or the absence of GlcNAc in the bisected 
portion of EG. The two GlcNAc's present in the mannose 
core were accounted for in the total of analysis. The 
fucoses and N-acetyl-galactosamines (GalNAc) were 
probably all detected, though present in small numbers. 
Since, blood group A was used for this study, and these 
residues are not normally present in all blood types, 
they represent the residues that confer group 
specificities to human blood.146
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The proton NMR spectrum (fig. 48a) confirmed the 
ratio of the sugar residues analyzed by GC. Since the 
sample was most likely a heterogeneous mixture of EG 
ranging around a molecular weight of 7 kDa, the peaks 
were broader than normal. Also, the ring proton region 
was not clearly separated into distinct peaks. Though 
sugars normally show a crowded ring proton region, 
assignment of the internal peaks is usually a matter of 
practice. However, in the case of EG this would be an 
impossible task. Only in the unlikely case of obtaining 
a micro-homogeneous sample would it be possible to obtain 
a clean NMR spectrum. The HPLC purification most likely 
did little to resolve this problem.
Figure 48a shows the 1-dimensional proton spectrum of 
7 kDa EG and figures 48b and 48c are the corresponding 
COSY and NOESY spectra. Three types of Gal's and two 
types of GlcNAc's were observed in the proton spectrum of 
EG. The gal's were assigned on the basis of a study of 
similar but shorter saccharides reported by Hounsell et 
al.I47 Thus, the most upfield gal was the internal gal, 
part of the polylactosamine chain and substituted with a 
lactosamine branch. The middle gal peak was assigned to 
the internal unsubstituted gal. The most downfield gal 
was the external gal, part of the branched lactosamine
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moiety. These assignments were confirmed from the NOESY 
spectrum of EG.
Only the interresidual cross-peaks are discussed 
here. The most upfield and middle gal showed a cross 
peak at the one of the GlcNAc H-4 proton, confirming the 
lactosaminyl linkage of 1-4. These GlcNAc's were hence 
the internal GlcNAc residues. The remaining gal showed a 
cross-peak at the H-4 proton of the other GlcNAc, 
indicating a lactosamine linkage in the branch point and 
confirming the position of the remaining GlcNAc in the 
proton spectrum. The internal GlcNAc's were not 
distinct in the spectrum. The GlcNAc with a downfield 
H-l proton showed a broad cross peak at the H-3 proton of 
the two internal Gal's, implying that the GlcNAc was 
internal and linked 1-3 to the two types of Gal 
(substituted and unsubstituted). The H-3 protons were 
not as differentiated as the H-l protons of Gal. The 
GlcNAc with the upfield H-l proton gave a cross peak at 
an unknown region of the proton spectrum around 3.70 ppm. 
This was most likely the H-6 proton of the internal 
substituted Gal, as the branching point was reported to 
be a 1-6 branch point from an internal Gal.
The presence of cross peaks from the mannoses was not 
detected due to their small amounts. Also, the core 
GlcNAc's were not detected in the proton spectra, but the
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likelihood of their being beneath the solvent peak cannot 
be ruled out. Surprisingly, the fucoses and GalNAc gave 
weak but definite cross peaks. The former gave a cross 
peak at the H-2 proton, and the latter the H-3 proton of 
the internal branched Gal. Since the GC analysis showed 
three times the amount of fucoses than GalNAc's some 
of the branch points most likely possessed only fucoses 
and others had both the blood group determinants. 
Using the reported presence of a branch point at every 
other Gal and no branch point at the reducing end Gal, 
the following structure is proposed for the 7 kDa EG:
F F F
I I I  
GaN-G-GN G-GN G-GN
I I I
G-GN-G-GN-G-GN-G-GN-G-GN-G-GN-M F
I I
M-GN-GN-Asn
I
G-GN-G-GN-G-GN-G-GN-G-GN-G-GN-M
I I I  
GaN-G-GN G-GN G-GN
I I I  
F F F
All residues are in the R anomeric configuration except 
GalNAc (GaN), the fucoses (F) and the branched mannoses 
(M). GN is GlcNAc and Asn is asparagine. The G-GN 
linkage is 1-4, the GN-G linkage is 1-3, the lactosaminyl 
branch point linkage is 1-6 and the blood group linkage 
is 1-2 between fucose and Gal, whereas it is 1-3 between
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GalNAc and Gal, as discussed above. The mannose core 
structure is a general N-linked sugar structure for bi- 
antennary type carbohydrates. The top polylactosamine 
chain is the 1-6 arm, whereas the bottom chain is the 1-3 
arm of the biantennary structure. Both the GlcNAc's are 
linked to 1-2 to the mannoses. In the mannosyl core, the 
mannose is linked 1-4 to GlcNAc, which is in turn, 
linked 1-4 to the "reducing" end GlcNAc. The "reducing" 
end fucose is 1-6 linked to the GlcNAc. This is the first 
study of the structure of intact high molecular weight EG 
using only two major NMR experiments (COSY and NOESY). 
However, extensive use was made of previous reports that 
used elaborate wet biochemical, GC-MS and NMR experiments 
of fragments of EG. With the availability of large 
amounts of purer samples, this study shows promise for 
the use of quick single experiments that elucidate the 
structure of high molecular weight biomolecules.
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Table 6. 1H chemical shifta and coupling constant data
for RKJ9 and RKJ10 in D2O solvent.
Residue Reporter
Group
RICJ9 
ppm (Hz)
RKJ10 
ppm (Hz)
GlcNAc H1 4.711 (8.4) 4.663 (8.4)
H2 3.808 (8.5. 10.6) 3.743 (10.0)
M3 3.396 00.4, 9.1) 3.649 (10.5, 8.8)
H4 3.55b 3.274 (9.4, 9.4)
H5 3.445 (10.1, 5.3, 2.4) 3.432 (9.8, 4.7, 2.3)
H6 3.890 (12.4, 2.3) 3.890 (2.2, 12.3)
H6' 3.751 (13.9, 5.9) 3.766 (5.9, 13.6)
NHCOCHj 2.037 2.029
och3 3.563 3.567
Gal HI 4.303 (8.0) 4.298 (8.0)
H2 3.543 (8.2, 6.6) 3.542 (9.8, 9.9)
H3 3.722 (5.5, 2.1) 3.696 (9.9, 3.5)
H4 4.130 (3.2) 4.132 (3.3)
H5 3.680 (7.6, 3.7) 3.654 (4.3, 10.5)
H6 3.765 (5.0, 14.4) 3.787 (8.0, 11.7)
H6' 3.713 (12.5, 2.6) 3.697 (4.4, 9.0)
OCHj 3.527 3.562
aAll chemical shifts reported at 
internal standard (2.225 ppm) 
relative to DSS.
bShift obtained from COSY.
29S C using 
indirectly
acetone as 
referenced
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Table 7. 1H chemical shift3 and coupling constant data
of RKJ9 and RKJ10 in 33 % D20 in DMS0-d6 solvent.
Residue Reporter RKJ9 RKJ10
Group ppm (Hz) ppm (Hz)
GlcNAc
Gal
H1 4.487 (B. 4 ) 4.443 (8.2)
H2 3.531 (8.6, 10.2) 3.473 (8.3, 8.3)
H3 3.138 (9.5, 9.5) 3.368 (7.3, 7.3)
H4 3.224 (9.1, 9.1) 2.952 (9.2, 9.2)
H5 3.15* 3.135 (9.7, 4.6, 2
H6 3.633 (10.6) 3.605 (11.2, 1.8)
H&' 3.456 (5.7, 12.2) 3.472 (5.5, 11.2)
NHCOCMj 1.815 1 .812
och3 3.337 3.368
HI 4.012 (7.8) 4.006 (7.6)
H2 3.303 (7.6, 9.3) 3.326 (7.7, 7.7)
H3 3.405 (9.7, 3.1) 3.377 (6.9, 3.8)
H4 3.827 (3.1) 3.828 (3.1)
K5 3.36b 3.307 (7.6, 3.6)
H6 3.486 (5.5, 11.7) n. e.
H6' 3.382 (3.1, 9.3) n. a.
och3 3.324 3.326
.0)
aAll chemical shifts reported at 298 °C relative to the 
solvent, dmso-d6 (2.49 ppm), as reference.
Shift obtained from COSY, 
n. a.: not available.
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Table 8. 13C chemical shift3 data of RKJ9 in 33 % D20 in
DMSO-d6 .
Residue Reporter RKJ9
Group ppm
GlcNAc
Gal
Cl 103.16
C2 55 . 14
C3 83 . 84
C4 69 .86
C5 76 . 87
C6 61. 51
NHCOCH3 23.59
OCH3 59 . 92
Cl 104.83
C2 70 .45
C3 61.42
C4 68 . 62
C5 82 . 88
C6 75.46
OCH3 57 . 35
aAll chemical shifts reported at 298 °C relative to the 
solvent, dmso-d6 (39.5 ppm), as reference.
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Table 9. chemical shift3 and coupling constant data
for RKJ11 in D20.
Residue Reporter RKJ11
Group ppm (Hz)
Gal
GlcNAc
HI 4 .43997 (7.67)
H2 3.21628 (7.78, 9. 94)
HI 3.61676 (9.98, 3.35)
H4 3.88367 (3.68)
H 5 3.65711 (4.00, 4. 00)
H6 3.74769 (3-85, 9 . 54)
H6 ' 3.70637 (2.86, 7.44)
OCHj 3.41304
HI 4.54135 (8.53)
H2 3.87626
CDCO 10.31)
H3 3.73528 *
H
►
a> 8.41)
H4 3.56146 (9.17, 9. 17)
H5 3.46882 (9.53, 5.70, 2.24)
H6 3.95218 (1.58, 12.38)
H6 ' 3.78659 (5.64, 12.40)
n h c o c h 3 1.93837
o c h 3 3.47881
aAll chemical shifts reported at 298 °K using acetone 
as internal standard (2.225 ppm) indirectly referenced 
relative to DSS.
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Table 10. N. O. e. data obtained by pre-irradiation of 
the indicated structural reporter groups of RKJ9 and 
RKJ10.
Glycoside Irradiation of
A H-l B H-l A H-4 0CH3a
Observed n. O. e.'s
RKJ9 A H-2
A H-3
A H-5
B H-3
RKJ10 A H-2
B H-3
B H-l
B H-2 OCH-,
OCH3* 3
a The upfield OCH3.
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Table 11. N . 0. e . data obtained by pre-irradiation of 
the indicated structural reporter groups of RKJ11.
Glycoside Irradiation of
A H-l B H-l OCH-
Observed n. O. e.'s
RKJ11 A H-2 B H-2 A H-2
A H-4 B H-3 B H-4
B H-3 B H-6
B H-6 Benzyl
Table 12. chemical shifts3 and coupling constant data
for RKJl and RKJ12 in D20.
Residue Reporter RKJ12 RKJl
Croup ppm (Hz) ppm (Hz)
Gal
GlcNAc
Gal
HI A.A39 (7.8) A.A79 (7.9)
H2 3.52A (7.6, 10.1) 3.5A0 (7.9, 10.5)
H3 3.6A2 (10.0, 3.3) 3.669 (10.0, 3.5)
HA 3.913 (2.9) 3.926 (3.A)
H5 3.703 (7.0, 3.7) 3.717 ( A ■ 1, 7.2)
H6 3.797 (3.5, 11.6) 3.828 (3.2, 9.A)
H6' 3.723 (A . 1, 8.7) 3.7A6 (5.6, 9.8)
Hi A.7A7 (8.A) A.718 (8.0)
H2 3.887 (8.1, 10.1) 3.79A (7.7, 7.7)
Hi 3.821 (8.5, 8.5) 3.761 (8.0, 8.0)
HA 3.565 (8.9, 8.9) 3.737 (7.3, 7.3)
H5 3.A80 (9.9, 5.0, 2.3) 3.582 (9.9, A.9,
H6 3.900 (2.5, 10.3) 3.958 (12.3, 2.2)
H6' 3.776 (A.2, 12.6) 3.8A6 (12.A, A.6)
nhcoch3 2.022 2.028
Hi A.306 (8.0) A.303 (8.0)
H2 3.550 (7.A, 10.7) 3.5A8 (7.8, 9.8)
h3 3.72A (9.7, 3.2) 3.713 (10.5, 3.8)
HA A.1A2 (3.3) A. 1A3 (3.A)
H5 3.68A (8.1, A.3) 3.673 (3.0, 7.1)
H6 3.79A (A. 1, 10.1) 3.798 (3.0, 9.8)
H6' 3.723 (A. 1, 8.7) 3.7A6 (5.6, 9.8)
oc«3 3.565 3.56A
2.A)
aAll chemical shifts reported at 298 °K using acetone 
as internal reference (2.225 ppm) indirectly referenced 
relative to DSS.
^Non-reducing end Gal, or residue A.
170
Table 13. N. O. e. data obtained by pre-irradiation of 
the indicated structural reporter groups of RKJ1 and 
RKJ12.
Glycoside Irradiation of
A H-l B H-l 0CH3
Observed n. O. e.'s
RKJ1 A H-2 B H-2 C H-l
A H-3 B H-6
B H-4 C H-3
B H-6
C H-4
A H-2 B H-2
B H-3 B H-6
B H-6 C H-3
RKJ12     C H-l
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Table 14. Relative ratios of sugar residues of 
erythroglycan obtained by GC analysis and from -NMR.
Sugar
Residue
Relative
GC
molar ratio 
NMR
GlcNAc 20 20
Ga 1 18 18
Fuc 6 6
GalNAc 2 2
Man 3 3
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Table 15. N. O. e. data obtained from the 2-dimensional 
NOESY experiment with EG.a
Irradiation
of
Observation of 
interresidual 
cross peak
G iu H-l GN* H-4
Gis H-l GN* H-4
Gb H-l GNb H-4
GN1 H-l Gi H-3
GNb H-l 10lX
&o
GaN H-l Gb H-3
F H-l Gb H-2
aG is Gal, GN is GlcNAc, GaN is GalNAc, F is fucose, i is 
internal, u is unsubstituted, s is substituted, and b is 
branched.
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Figure 29. structures of (a)RKJ9 and (b)RKJ10.
protons are not shown.
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F i g u r e  3 0 .  400 MHz (a) 1-dimensional 1H and (b)
COSY 90 spectra of RKJ9 in D20.
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Figure 31. 400 MHz (a) 1-dimensional and (b)
COSY 90 spectra Of RKJ9 in 33 % DjO in DMSO-d6.
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F i g u r e  32. 400 MHz (a) 1-dimensional -LJC and
HETCOR spectra of RKJ9 in 33 % d 2o
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in DMSO-d6 .
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Figure 33. Selective i n e p t experiment of RKJ9 in 33 %
DzO in DMSO-d6.
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Figure 34. N. O. e. difference spectroscopy experiments
with pre-irradiation of (a) Aj^ and (b) upfield O-methyl
protons of RKJ9.
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Figure 35. 400 MHz (a) i-dimensional and (b) *H-
COSY 90 spectra of RKJ10 in D20 .
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Figure 36. 400 MHz (a) 1-dimensional and (b) 1H-
COSY 90 spectra of RKJ10 in 33 % D20 in DMSO-d6,
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Figure 37. N. O. e. difference spectroscopy experiments
with pre-irradiation of (a) AH4 (b) AH1 and (c) BH1
protons of RKJ10.
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Figure 38. 400 MHz l-dimensional 13C spectrum of RKJ10
in 33 % D20 in DMSO-d6.
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Figure 39. Structure of RKJll. Some protons are not 
shown.
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Figure 40. 400 MHz (a) l-dimensional H and fb) 1H-1H
COSY 90 spectra of RKJ11 in D20. Peaks on either side of 
the solvent (HOD) are spinning side bands.
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Figure 41. N. O. e. difference spectroscopy experiments
with pre-irradiation of (a) o-methyl (bj AH1 (c) BH1
protons of RKJ11.
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Figure 42. Structures of (a)RKJl and (b)RKJ12. Some
protons are not shown.
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Figure 43. 400 MHz (a) l-dimensional *H and (b) 1H-
COSY 90 spectra of RKJl in D20.
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Figura 44. N. O. e. difference spectroscopy experiments
with pre-irradiation of (a) O-methyl (b) and (c) AH1
protons of RKJ1.
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Figure 45. 400 MHz (a) l-dimensional 1H and (b) 1H-
COSY 90 spectra of RKJ12 in D20.
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Figure 46. N. O. e. difference spectroscopy experiments
with pre-irradiation of (a) 0-methyl (b) A„, and (c) BU1
protons of RKJ12.
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Figure 47. Long range COSY experiment of RKJ5.
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Figure 48. 400 MHz (a) 1-dimensional H (b) COSY 90
spectrum is below the diagonal and (c) NOESY spectrum of 
erythroglycan is above the diagonal.
C H A P T E R  5. AN NMR STUDY OF THE T H E R M O D Y N A M I C  
INTERACTIONS OF CONCANAVALIN A-a-METHYL GLUCOPYRANOSIDE
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INTRODUCTION
The binding of a lectin (P) to it's ligand (L) is a 
simple bimolecular process that can be represented by the 
following reaction:
L + P ^========^ pa
where PA is the bound lectin-ligand complex. Like all 
chemical reactions, this binding process can be presumed 
to proceed through a transition state characterized by an 
activated transition state complex [PA]"K
L + P ^=======^ [PA]+ s==========^ PA
The energetics of the lectin and ligand binding are 
obtained by estimating the thermodynamic parameters such 
as the Gibbs free energy, enthalpy and entropy of binding 
for the complex. The relationship between these 
parameters and the dissociation constant (Kd) is given by 
the equation:
dG° dH° dS°
In (Kd)  ----------- =   -   (2)
RT RT R
Kd is also given by the ratio of the dissociation and 
associaion rate constants (kd/ka), The dissociation
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constant was obtained in this study by employing nuclear 
magnetic resonance (NMR) titration experiments. NMR 
studies afford a more accurate estimate of such constants 
compared with the conventional inhibition experiments 
that employ radiolabelled glycopeptides or proteins. The 
NMR experiment involves keeping the protein concentration 
invariant and varying the ligand concentration, while 
monitoring the chemical shift and line width changes of 
protons of the ligand. These changes are then 
correlated with the thermodynamic parameters and 
discussed in detail below.
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MATERIALS AND METHODS
Materials. Concanavalin A and methyl a-gluco- 
pyranoside were obtained from Sigma Chemical Co., St. 
Louis, MO. Bio-rad protein assay kit was obtained from 
Bio-rad, Richmond, CA. D2°> 99*9 and 99.96 atom %, were
obtained from MSD Isotopes, Rahway, NJ. 5 mm NMR tubes
(528PP) were obtained from Wilmad Glass Co., Inc., Buena, 
NJ.
Methods. Proton magnetic resonance spectroscopy was 
performed on thrice freeze-dried, deuterium exchanged 
samples. Protein and ligand were separately dissolved in 
10 mM phosphate buffer, the protein buffer supplemented 
with Ca2 + and Mg2 + to give a molar ratio of 2:1 for each 
metal to protein molar ratios. The protein solution was 
centrifuged at 15000 X g for a minute to remove 
undissolved substance and concentration, kept constant at 
0.1 mM was assayed using the Bio-rad protein assay kit. 
The concentration was confirmed spectrophotometrically at 
280 nm using an absorbance of A 1*' lcni = 12.4 at pH 
5.6 . 158 Ligand concentrations were varied from 0 to 40 
mM. Small amounts of concentrated ligand solution were 
added to the protein solution and the final protein 
concentration corrected for the change in volume. pH 
values were checked occasionally and were within ± 0.1
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units of the reported values. pH values are not 
corrected for the deuterated solutions. Control 
experiment at each tempature consisted of free ligand in 
the absence of the protein.
Experiments were performed using a Bruker AM-400 
spectrometer equipped with an Aspect 3000 computer. 16 
to 1024 scans were taken depending on the ligand 
concentration, with a sweep width of 5 kHz, a 2-s pulse 
delay, 16K data points, without solvent peak suppression. 
A line broadening of 0.1 Hz was used after Fourier 
transformation of the free induction decay. Chemical 
shifts were measured with reference to internal acetone 
(2.225 ppm), indirectly referenced relative to 2, 2-
dimethyl-2-silapentane-5-sulfonic acid (DSS). Peaks were 
assigned by running a correlation spectroscopy (COSY) 
experiment (data not shown), prior to the titration 
studies. The experiments were run at four different 
temparatures: 308, 318, 328 and room temparature,
2 98 °K.
198
RESULTS AND DISCUSSION
NMR titration studies done with a constant protein
concentration and with varying ligand concentration,
showed different extents of line broadening and chemical
shift changes for the protons on the ligand.
Maximum changes were observed for the H-3 and H-4
protons. Comparatively, small changes were observed for
the H-2 and H-5 protons of the methyl glucoside, in
1 d flkeeping with the observations of Goldstein et al .1'0 and 
Poretz and Goldstein 149. These researchers reported 
that, for interaction to occur, the ligand must have 
either a D-manno or D-gluco configuration, with the 
former being a stronger association. It was also 
reported that unmodified hydroxyl groups were needed on 
the protons on carbons C-3, C-4, and C-6 . Thus, the 
protons H-2 and probably H-5 do not play an appreciable 
role in lectin-ligand binding.
Dissociation constants obtained at four different 
temparatures are given in table 16. These values were 
obtained from the y intercept of a plot of ligand 
concentration versus reciprocal of the change in chemical 
shift of proton H-3 (fig. 49) of the ligand, methyl 
glucopyranoside (fig. 50). The H-3 proton was chosen for 
analysis because of the greater extent of the chemical 
shift and line width changes (fig. 49). The
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resonance H-4 also showed appreciable changes. At 
lower ligand concentrations, the resonance shifted 
towards and was obscured by the large methyl peak at 
about 3.40 ppm. The H-3 resonance conincided with the H- 
5 resonance but the peaks were differentiated enough for 
chemical shift and line width calculations. Calculations 
of thermodynamic parameters from chemical shift changes 
paralleled those from line width changes, and the former 
was chosen for the estimations. With increasing 
temparature, the values decreased indicati ng a
diminution in the binding of the lectin and ligand. A
four fold decrease in binding was observed with values
increasing from 0.25 mM to 0.91 mM with an increase in 
temparature from 25 °C to 55 °C. A van't Hoff plot of
ln(Kcj) versus reciprocal of the corresponding temparature 
values afforded the enthalpy values, as shown in figure 
51. The Gibbs free energies were obtained directly from 
equation 2 above and the entropies were calculated from 
the same equation. The latter values can also be
obtained from the van't Hoff plot as a y intercept.
Table 17 lists the thermodynamic parameters of 
binding. These are compared with values obtained from 
affinity electrophoresis.150 Also given in the table are 
values obtained from binding studies of wheat germ 
agglutinin (WGA) and sialic acid.^5  ^ A Gibb's free energy
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of -4.93 ± 0.5 kcal mol-1 was obtained from this study 
and compares we11 with a value of -4.7 kcal mol-1
obtained with the affinity electrophoresis method. The 
dG° value for WGA-sialic acid binding was -3.8 ± 0.4 kcal 
mol-1. However, large differences were noted in the 
enthalpy and entropy values. A higher enthalpy of 
-8.84 ± 0.9 kcal mol-1 was obtained in this study
compared with a value of -6.2 kcal mol-1 obtained with 
the affinity equilibrium experiment; but the entropy
value calculated was lower (3.91 ± 0.4 kcal mol-1)
compared with the latter (5.2 kcal mol-1). The 
differences in entropy values between con A-methyl 
glucopyranoside binding in comparison with WGA-sialic 
acid binding were quite large. This accounts for the
millimolar affinities to binding of WGA and sialic acid. 
The binding of con A and methyl glucopyranoside, on the 
other hand, was four times stronger when compared with 
WGA-sialic acid binding (KD = 0.264 mM for the former, KD 
^ 1 mM for the latter). It is of interest to note the
positive equilibrium entropy of association of +3.91 ±
0.4 kcal mol- . This is most likely due to the loss of 
the six translational and rotational degrees of 
freedom.152' 153 The entropy factor however, was only 44 
percent of the enthalpy of binding. The energy gained 
in enthalpy of binding was thus more than offset by the 
unfavorable entropy interaction. Ross et a l .153 have
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reported that hydrogen bonds and van der Waal's forces 
contribute to the enthalpy of bound complexes. Such 
forces are most likely involved in the Con A- 
glucopyranoside interaction. An alternate scheme of 
interaction predicts hydrophobic interaction arising from 
the binding. Kabat et al .154 had argued on the basis of 
agglutination inhibition specificities that a hydrophobic 
patch of sugar was driven to a hydrophobic region on the 
protein. However, such interactions being entropically 
favored, result in negative -TdS° values and can be 
discounted for the case of Con A-glucopyranoside binding.
On the other hand, ionic forces are characterized by 
negative -TdS° values and small positive or negative dH° 
values. In the past, it was assumed that polar or ionic 
interaction played a major role in protein-carbohydrate
IKE, ICC 1 C'l 1 CD
recognition. J J However, there was 
little evidence of substance to support this proposition. 
Even in the case of basic WGA binding to acidic sialic 
acid, the contribution of ionic forces to the overall 
free energy of binding was argued to be negligible.151 
This was in contradiction to the earlier proposition of 
Honsigny et al. for this system.159 In the case of Con A 
binding to neutral glucopyranoside, such interactions can 
be safely assumed to be less important than hydrogen 
bonds and van der Waal's forces. This proposition is
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made despite the fact that cations such as Mn2 + and Ca2 + 
are crucial for the binding properties of Con A .160 The 
thermodynamic parameters obtained for the Con A- 
glucopyranoside system substantiate such a proposition. 
With a positive value for -TdS° and a large enthalpy 
contribution of -8.84 ± 0.9 kcal mol-1 to the free energy 
of binding, the ionic forces are not likely to be as 
important in the interaction as the other forces 
discussed above. This was also substantiated by 
unpublished observations in related studies of
swainsonine inhibition of mannosidase, where tight
binding of the enzyme-inhibitor could not be disrupted by 
strong salt concentrations.
The high resolution three-dimensional structure of 
crystalline concanavalin A from X-ray crystallographic 
studies, was reported independently by two groups in 
1972 . 162 a pocket about 20 A deep which was first
thought to be the sugar binding site, was later reported 
to bind non-specifically to nonpolar aromatic aglycones 
used in binding studies.163 The binucleated region 
formed from Ca2 + and Mn2+ was reported to be 9-11 A from 
the surface of the con A molecule,16  ^ but was also
reported to be about 2 0 A from the saccharide binding 
site. The latter observations explain the negligible 
role played by ionic forces in the sugar binding
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interactions, and also of the inability of salt solutions 
to affect the sugar-lectin bond. Also, because of the 
non-proximity of the metal site and the sugar-binding 
site, the amino acids coordinated or interacting with 
either or both the Ca2+ and the transition metal, cannot 
be involved with sugar binding. The reverse however, is 
most likely not true. Amino acids involved in their 
interaction with bound sugars also indirectly interact 
with the metal sites, either through other amino acids, 
or through a property of the tertiary or quaternary 
structure of the protein. This is because, the absence 
of one or both of Ca* and another transition metal 
prevented sugar binding165. This effect was reported to 
be reversible, indicating a communication between the 
metal binding and sugar binding sites.
Hardman et al. proposed side chains of Asp-16, Tyr-
12, Arg-229, and Tyr-101 to be involved with sugar
binding.166 Thus, four to five hydrogen bonds are
involved in the binding of con A to the sugar moiety,
with binding most likely involving protons H-l, H-3, H-4,
H-6 , and H-6 ' of methyl glucopyranoside. Assuming small
contribution to the enthalpy of binding by van der Waal's
forces, the contribution by each hydrogen bond to the
enthalpy would be in the range of 1.7 to 2.2 kcal mol-1,
167which is reasonable for hydrogen bond strengths.
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In conclusion, NMR titration studies afforded 
direct experimental evidence of parts of ligand molecule 
that interact with 1igand binding sites on lectin. The 
importance of NMR is evident from the fact that it 
precludes the need to synthesize numerous compounds that 
are similar to the natural ligand but differ slightly in 
certain portions of the molecule.
Protons H-l, H-3, H-4, H-6 , and H-6 ' of methyl
glucopyranoside were found to be involved in the 
interaction with con A. The interaction was entropically 
unfavored but was driven by a favorable enthalpy of 
binding. Such interaction indicates the importance of 
hydrogen bonding and van der Waal's forces, as opposed to 
ionic or hydrophobic effects. The involvement of such 
forces seem universal in lectin-ligand binding. Such 
experiments provide a good working model for the study of 
protein-ligand interaction.
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Table 16. Dissociation constants at various temparatures 
for Con A- methyl glucopyranoside binding.
Temparature Kj * mM
deg K
298
308
318
328
0.246 ± 0.02 
0.354 ± 0.04 
0.694 ± 0.07 
0.914 ± 0.09
*Correlation coefficients greater than 0.96 were obtained 
in each case.
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Table 17. Thermodynamic parameters for lectin-sugar 
interaction.
Thermodynamic parameter Value kcal mol^ 1
from reference 
1 2  3
dG° -4 . 9 + 0 . 5 i * -3 . 8 + 0.4
a X 0 -8 . 8 + 0 . 9 -6.2 -13 . 3 + 1.0
-ds° + 3 . 9 ± 0.4 + 5 . 2 + 9.5 + 0.7
1. This study; 2. Reference 150; and 3. Reference 
151, no error values were reported. The last reference 
is for WGA-sialic acid binding.
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Figure 49. NMR spectra of methyl glucopyranoside at
various concentrations ranging from 0.5 mM (top) to 2 mM 
(bottom) in the absence (bottom) or presence of 0.1 mM 
protein (top 4).
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Figure 50. Determination of the dissociation constant 
of Con A-methyl glucopyranoside binding, at 298 °K.
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Figure 51. A van't Hoff plot of the binding of Con A and 
methyl glucopyranoside. The dashed lines represent 
estimates on the error in the fits.
SUMMARY
Invasion assays of P. falciparum using erythro- 
glycan, the carbohydrate portion of band 3 of human red 
cells, showed micromolar levels of inhibition. This 
indicates the involvement of erythroglycan in the 
receptor recognition by parasite proteins. The 
inhibition was more potent with higher molecular weight 
fractions, indicating preferred binding of parasite 
proteins to the ligand due to multivalent attachment. 
Also, higher molecular weight fractions of erythroglycan 
neoglycoproteins were ten times more potent than the free 
sugars in inhibiting P. falciparum invasion. The 
neoglycoprotein assays indicate that the involvement of 
the protein portion of band 3 in parasite recognition may 
not be crucial. However, the presence of a protein 
provides for a preferred conformation of the sugar for 
interaction with a parasite. At least two parasite 
receptors were detected on affinity columns immobilized 
with erythroglycan. A 118 kDa parasite protein is 
reported for the first time and is probably specifically 
involved with binding to erythroglycan. The involvement 
of erythroglycan was vindicated by studies involving 
abnormal HEMPAS red cells. HEMPAS is a form of anemia 
characterized by a truncated erythroglycan. Invasion and 
growth of parasite was reduced in these cells.
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Structural studies of di- and trisaccharides related 
to erythroglycan provided means to characterize the 
latter. Using high resolution NMR studies and 1- and 2- 
dimensional experiments, anomeric configuration, epimer 
order, ring size and linkage information was obtained. 
Information was extracted for the structural elucidation 
of erythroglycan. For the first time, intact and 
underivatized, high molecular weight (7 kDa) erythro­
glycan was characterized. A biantennary structure 
containing long N-acety1-polylactosamine and 1-6 branch 
points on alternating galactoses was observed. Also, 
since blood group A was used, N-acetyl-galactosamine and 
fucoses were detected, linked 1-3 and 1-2 to the branched 
galactoses, respectively.
Finally, model binding studies of Concanavalin A and 
methyl a-glucopyranoside using NMR titration experiments, 
showed the involvement of hydrogen bonds and van der 
Waal's force in the binding. An unfavorable positive 
entropy and a large favorable enthalpy seems to be the 
universal characteristics of lectin-ligand interaction 
even when ionic proteins and ligands are involved in the 
binding. These studies provide means of elucidating 
such details in higher systems. Future work can be 
directed at studying specific parasite proteins that 
interact with erythroglycan.
FUTURE WORK
In the absence of detailed knowledge of specific 
parasite protein that could be interacting with 
erythroglycan (EG), binding studies were done with a 
simple system of concanavalin binding to methyl 
glucopyranoside. The method used to study the binding 
can be applied in future to study parasite protein 
interaction with EG. The 118 kDa protein immobilized on 
the EG affinity column is also most likely involved in EG 
binding prior to invasion. Confirmation of the binding 
would be essential to such studies. Purification of this 
protein would be a major project by itself.
Use of high resolution NMR illustrated some of the 
recent techniques used for structural characterizations. 
These preclude the need to work with derivatized or 
fragmented samples. The location of blood groups on the 
branch points could not be easily discerned. It is not 
known whether they are situated on regular or random 
sites on branch points. A combination of enzymatic and 
structural studies are needed to probe this problem. Use 
of a specific exo-glycosidase, modern separation 
techniques and structure elucidation using NMR or mass 
spectrometry would provide challenge in areas as varied 
as enzymology, separation science and structural biology.
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